Probe Set	Gene Symbol	Genbank	FC AGC/EGC	Description	Chromosomal Location	Alignments of probe sets to the genome	GO biological process	GO molecular function
37892_at	COL11A1	J04177	19.12	collagen, type XI, alpha 1	chr1p21	chr1:103115535-103346483 (-)	1502 ; cartilage condensation ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7601 ; visual perception ; traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation ; 16337 ; cell-cell adhesion ; non-traceable author statement ; 30198 ; extracellular matrix organization and biogenesis ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 30674 ; protein binding, bridging ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; inferred from electronic annotation
217428_s_at	COL10A1	X98568	17.81	collagen, type X, alpha 1(Schmid metaphyseal chondrodysplasia)	chr6q21-q22	chr6:116546882-116553989 (-)	1501 ; skeletal development ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
209955_s_at	FAP	U76833	10.53	fibroblast activation protein, alpha	chr2q23	chr2:162735699-162808131 (-)	6508 ; proteolysis ; inferred from electronic annotation	4222 ; metalloendopeptidase activity ; traceable author statement ; 4274 ; dipeptidyl-peptidase IV activity ; non-traceable author statement ; 4287 ; prolyl oligopeptidase activity ; inferred from electronic annotation ; 42803 ; protein homodimerization activity ; non-traceable author statement ; 8236 ; serine-type peptidase activity ; inferred from mutant phenotype ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 4274 ; dipeptidyl-peptidase IV activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8236 ; serine-type peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8236 ; serine-type peptidase activity ; non-traceable author statement ; 46983 ; protein dimerization activity ; non-traceable author statement
235458_at	HAVCR2	AW025572	9.83	hepatitis A virus cellular receptor 2	chr5q33.3	chr5:156445420-156446166 (-)
204320_at	COL11A1	NM_001854	9.73	collagen, type XI, alpha 1	chr1p21	chr1:103115602-103346483 (-)	1502 ; cartilage condensation ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7601 ; visual perception ; traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation ; 16337 ; cell-cell adhesion ; non-traceable author statement ; 30198 ; extracellular matrix organization and biogenesis ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 30674 ; protein binding, bridging ; non-traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; inferred from electronic annotation
205941_s_at	COL10A1	AI376003	9.24	collagen, type X, alpha 1(Schmid metaphyseal chondrodysplasia)	chr6q21-q22	chr6:116546813-116553756 (-)	1501 ; skeletal development ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
204052_s_at	SFRP4	NM_003014	7.46	secreted frizzled-related protein 4	chr7p14.1	chr7:37912067-37922902 (-)	16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
226930_at	FNDC1	AI345957	7.23	fibronectin type III domain containing 1	chr6q25	chr6:159580753-159613130 (+)
205422_s_at	ITGBL1	NM_004791	6.21	integrin, beta-like 1 (with EGF-like repeat domains)	chr13q33	chr13:100902966-101166794 (+)	7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement ; 7160 ; cell-matrix adhesion ; inferred from electronic annotation ; 7229 ; integrin-mediated signaling pathway ; inferred from electronic annotation	8083 ; growth factor activity ; inferred from electronic annotation
226311_at		BF058422	6.20	CDNA clone IMAGE:30924414	chr5	chr5:178470460-178471956 (-)
222288_at		AI004009	6.13	Transcribed locus	chr3p13	chr3:73111607-73112033 (+)
231993_at		AK026784	5.67	CDNA: FLJ23131 fis, clone LNG08502	chr13	chr13:101169307-101171207 (+)
226237_at	COL8A1	AL359062	5.59	Collagen, type VIII, alpha 1	chr3q12.3	chr3:100998994-101000750 (+)	6817 ; phosphate transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7525 ; somatic muscle development ; non-traceable author statement	5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
223122_s_at	SFRP2	AF311912	5.53	secreted frizzled-related protein 2	chr4q31.3	chr4:154921191-154929674 (-)	16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
210511_s_at	INHBA	M13436	5.39	inhibin, beta A (activin A, activin AB alpha polypeptide)	chr7p15-p13	chr7:41695656-41706734 (-)	1501 ; skeletal development ; traceable author statement ; 1541 ; ovarian follicle development ; non-traceable author statement ; 6917 ; induction of apoptosis ; inferred from direct assay ; 6952 ; defense response ; traceable author statement ; 7050 ; cell cycle arrest ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 7399 ; nervous system development ; non-traceable author statement ; 7498 ; mesoderm development ; inferred from sequence or structural similarity ; 9605 ; response to external stimulus ; traceable author statement ; 30154 ; cell differentiation ; traceable author statement ; 30218 ; erythrocyte differentiation ; non-traceable author statement ; 40007 ; growth ; inferred from electronic annotation ; 42326 ; negative regulation of phosphorylation ; traceable author statement ; 42541 ; hemoglobin biosynthesis ; inferred from direct assay ; 45077 ; negative regulation of interferon-gamma biosynthesis ; traceable author statement ; 45578 ; negative regulation of B cell differentiation ; traceable author statement ; 45650 ; negative regulation of macrophage differentiation ; traceable author statement ; 46881 ; positive regulation of follicle-stimulating hormone secretion ; traceable author statement ; 46882 ; negative regulation of follicle-stimulating hormone secretion ; non-traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 45786 ; negative regulation of progression through cell cycle ; traceable author statement ; 1541 ; ovarian follicle development ; inferred from sequence or structural similarity ; 6917 ; induction of apoptosis ; inferred from sequence or structural similarity ; 6952 ; defense response ; inferred from sequence or structural similarity ; 7050 ; cell cycle arrest ; inferred from sequence or structural similarity ; 7166 ; cell surface receptor linked signal transduction ; inferred from sequence or structural similarity ; 7267 ; cell-cell signaling ; inferred from sequence or structural similarity ; 7399 ; nervous system development ; inferred from sequence or structural similarity ; 30154 ; cell differentiation ; inferred from sequence or structural similarity ; 30218 ; erythrocyte differentiation ; inferred from sequence or structural similarity ; 42326 ; negative regulation of phosphorylation ; inferred from sequence or structural similarity ; 42541 ; hemoglobin biosynthesis ; inferred from sequence or structural similarity ; 45077 ; negative regulation of interferon-gamma biosynthesis ; inferred from sequence or structural similarity ; 45578 ; negative regulation of B cell differentiation ; inferred from sequence or structural similarity ; 45650 ; negative regulation of macrophage differentiation ; inferred from sequence or structural similarity ; 45786 ; negative regulation of progression through cell cycle ; inferred from sequence or structural similarity ; 46881 ; positive regulation of follicle-stimulating hormone secretion ; inferred from sequence or structural similarity ; 46882 ; negative regulation of follicle-stimulating hormone secretion ; inferred from sequence or structural similarity	5125 ; cytokine activity ; traceable author statement ; 5160 ; transforming growth factor beta receptor binding ; not recorded ; 5179 ; hormone activity ; inferred from electronic annotation ; 5179 ; hormone activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8083 ; growth factor activity ; inferred from electronic annotation ; 8083 ; growth factor activity ; traceable author statement ; 17106 ; activin inhibitor activity ; traceable author statement ; 5125 ; cytokine activity ; inferred from sequence or structural similarity ; 5179 ; hormone activity ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 8083 ; growth factor activity ; inferred from sequence or structural similarity ; 17106 ; activin inhibitor activity ; inferred from sequence or structural similarity
203819_s_at	IMP-3	AU160004	5.23	IGF-II mRNA-binding protein 3	chr7p11	chr6:167032838-167036566 (-)	6396 ; RNA processing ; traceable author statement ; 6412 ; protein biosynthesis ; traceable author statement ; 9653 ; morphogenesis ; traceable author statement	3676 ; nucleic acid binding ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; traceable author statement
212464_s_at	FN1	X02761	5.12	fibronectin 1	chr2q34	chr2:215933832-216008690 (-)	6953 ; acute-phase response ; inferred from electronic annotation ; 7155 ; cell adhesion ; non-traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 9611 ; response to wounding ; non-traceable author statement ; 16477 ; cell migration ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 5518 ; collagen binding ; non-traceable author statement ; 8201 ; heparin binding ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
212353_at	SULF1	AI479175	5.10	sulfatase 1	chr8q13.2-q13.3	chr8:70576662-70735701 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 30201 ; heparan sulfate proteoglycan metabolism ; non-traceable author statement	4065 ; arylsulfatase activity ; inferred from direct assay ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8484 ; sulfuric ester hydrolase activity ; inferred from electronic annotation
227995_at		AI051950	5.06	MRNA; cDNA DKFZp564O0862 (from clone DKFZp564O0862)	chr10	chr10:20618115-20618788 (+)
225681_at	CTHRC1	AA584310	4.93	collagen triple helix repeat containing 1	chr8q22.3	chr8:104452907-104464397 (+)	6817 ; phosphate transport ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation
216442_x_at	FN1	AK026737	4.76	fibronectin 1	chr2q34	chr2:215933833-215936012 (-)	6953 ; acute-phase response ; inferred from electronic annotation ; 7155 ; cell adhesion ; non-traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 9611 ; response to wounding ; non-traceable author statement ; 16477 ; cell migration ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 5518 ; collagen binding ; non-traceable author statement ; 8201 ; heparin binding ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
223121_s_at	SFRP2	AW003584	4.69	secreted frizzled-related protein 2	chr4q31.3	chr4:154921192-154929677 (-)	16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
211719_x_at	FN1	BC005858	4.69	fibronectin 1 ; fibronectin 1	chr2q34	chrX:80824065-80824699 (+)	6953 ; acute-phase response ; inferred from electronic annotation ; 7155 ; cell adhesion ; non-traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 9611 ; response to wounding ; non-traceable author statement ; 16477 ; cell migration ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 5518 ; collagen binding ; non-traceable author statement ; 8201 ; heparin binding ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
204776_at	THBS4	NM_003248	4.53	thrombospondin 4	chr5q13	chr5:79367095-79414861 (+)	6930 ; substrate-bound cell migration, cell extension ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation
210495_x_at	FN1; CIG; MSF; FINC; LETS	AF130095	4.45	fibronectin 1	chr2q34	chr2:215933833-215948660 (-)	6953 ; acute-phase response ; inferred from electronic annotation ; 7155 ; cell adhesion ; non-traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 9611 ; response to wounding ; non-traceable author statement ; 16477 ; cell migration ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; non-traceable author statement ; 5518 ; collagen binding ; non-traceable author statement ; 8201 ; heparin binding ; non-traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
202800_at	SLC1A3	NM_004172	4.38	solute carrier family 1 (glial high affinity glutamate transporter), member 3	chr5p13	chr5:36642511-36724191 (+)	1504 ; neurotransmitter uptake ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6835 ; dicarboxylic acid transport ; inferred from electronic annotation ; 7268 ; synaptic transmission ; traceable author statement ; 15813 ; L-glutamate transport ; traceable author statement	5313 ; L-glutamate transporter activity ; traceable author statement ; 15293 ; symporter activity ; inferred from electronic annotation ; 17153 ; sodium:dicarboxylate symporter activity ; inferred from electronic annotation
214927_at		AL359052	4.32	Integrin, beta-like 1 (with EGF-like repeat domains)	chr13q33	chr13:101157119-101169132 (+)	7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement ; 7160 ; cell-matrix adhesion ; inferred from electronic annotation ; 7229 ; integrin-mediated signaling pathway ; inferred from electronic annotation	8083 ; growth factor activity ; inferred from electronic annotation
212354_at	SULF1	BE500977	4.26	sulfatase 1	chr8q13.2-q13.3	chr8:70576662-70735701 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 30201 ; heparan sulfate proteoglycan metabolism ; non-traceable author statement	4065 ; arylsulfatase activity ; inferred from direct assay ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8484 ; sulfuric ester hydrolase activity ; inferred from electronic annotation
238654_at	LOC147645	W79425	4.18	hypothetical protein LOC147645	chr19q13.33	chr19:56526608-56527212 (-)
213943_at	TWIST1	X99268	4.16	twist homolog 1 (acrocephalosyndactyly 3; Saethre-Chotzen syndrome) (Drosophila)	chr7p21.2	chr7:19121615-19123809 (-)	122 ; negative regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 1501 ; skeletal development ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7001 ; chromosome organization and biogenesis (sensu Eukaryota) ; traceable author statement ; 9653 ; morphogenesis ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3702 ; RNA polymerase II transcription factor activity ; not recorded ; 4857 ; enzyme inhibitor activity ; traceable author statement ; 5515 ; protein binding ; traceable author statement ; 30528 ; transcription regulator activity ; inferred from electronic annotation
236028_at	IBSP	BE466675	4.13	Integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein II)	chr4q21-q25	chr4:88952141-88952611 (+)	1503 ; ossification ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
212746_s_at	KAB	AA126789	3.98	KIAA0470	chr1q44	chr4:119654597-119696626 (+)
203548_s_at	LPL	BF672975	3.94	lipoprotein lipase	chr8p22	chr8:19841032-19869049 (+)	6631 ; fatty acid metabolism ; not recorded ; 8015 ; circulation ; traceable author statement ; 16042 ; lipid catabolism ; inferred from electronic annotation ; 6629 ; lipid metabolism ; inferred from electronic annotation	4465 ; lipoprotein lipase activity ; traceable author statement ; 5319 ; lipid transporter activity ; inferred from electronic annotation ; 8201 ; heparin binding ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4465 ; lipoprotein lipase activity ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
201147_s_at	TIMP3	BF347089	3.90	TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory)	chr22q12.1-q13.2|22q12.3	chr22:31526807-31589030 (+)	7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 7600 ; sensory perception ; inferred from electronic annotation ; 7601 ; visual perception ; inferred from electronic annotation ; 8624 ; induction of apoptosis by extracellular signals ; non-traceable author statement	4857 ; enzyme inhibitor activity ; inferred from electronic annotation ; 8191 ; metalloendopeptidase inhibitor activity ; inferred from electronic annotation ; 8191 ; metalloendopeptidase inhibitor activity ; not recorded
205206_at	KAL1	NM_000216	3.83	Kallmann syndrome 1 sequence	chrXp22.32	chrX:8456914-8660227 (-)	6928 ; cell motility ; traceable author statement ; 6935 ; chemotaxis ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 7411 ; axon guidance ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation
212469_at	NIPBL	AB019494	3.78	Nipped-B homolog (Drosophila)	chr5p13.2	chr5:37012021-37101677 (+)	7049 ; cell cycle ; inferred from electronic annotation	5488 ; binding ; inferred from electronic annotation
241780_at	CDH11	AI040305	3.77	Cadherin 11, type 2, OB-cadherin (osteoblast)	chr16q22.1	chr16:63576100-63576469 (-)	1503 ; ossification ; non-traceable author statement ; 7156 ; homophilic cell adhesion ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation ; 1501 ; skeletal development ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 16337 ; cell-cell adhesion ; non-traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
221731_x_at	CSPG2	BF218922	3.76	chondroitin sulfate proteoglycan 2 (versican)	chr5q14.3	chr5:82871494-82913877 (+)	7275 ; development ; traceable author statement ; 8037 ; cell recognition ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5529 ; sugar binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; traceable author statement ; 5540 ; hyaluronic acid binding ; inferred from electronic annotation ; 5539 ; glycosaminoglycan binding ; traceable author statement
232155_at	KIAA1618	AK023113	3.74	KIAA1618	chr17q25.3	chr17:75894760-75908904 (+)		3824 ; catalytic activity ; inferred from electronic annotation
219387_at	KIAA1212	NM_017571	3.72	KIAA1212	chr2p16.1	chr2:55414957-55500253 (-)
220129_at	FLJ20449	NM_017826	3.69	hypothetical protein FLJ20449	chr13q13.3	chr13:35640354-35686676 (-)	45449 ; regulation of transcription ; inferred from electronic annotation	30528 ; transcription regulator activity ; inferred from electronic annotation
202404_s_at	COL1A2	NM_000089	3.61	collagen, type I, alpha 2	chr7q22.1	chr7:93862142-93898480 (+)	1501 ; skeletal development ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 8147 ; structural constituent of bone ; not recorded ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; non-traceable author statement
215446_s_at	LOX	L16895	3.60	lysyl oxidase	chr5q23.2	chr5:121428280-121430343 (-)	6464 ; protein modification ; traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement	4720 ; protein-lysine 6-oxidase activity ; traceable author statement ; 5507 ; copper ion binding ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4720 ; protein-lysine 6-oxidase activity ; inferred from electronic annotation ; 5507 ; copper ion binding ; inferred from electronic annotation
236179_at	CDH11	AI754693	3.55	Cadherin 11, type 2, OB-cadherin (osteoblast)	chr16	chr16:63536631-63537130 (-)	1503 ; ossification ; non-traceable author statement ; 7156 ; homophilic cell adhesion ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation ; 1501 ; skeletal development ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 16337 ; cell-cell adhesion ; non-traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
222020_s_at	HNT	AW117456	3.55	neurotrimin	chr11q25	chr11:131586871-131710946 (+)	7155 ; cell adhesion ; non-traceable author statement ; 8038 ; neuron recognition ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
205572_at	ANGPT2	NM_001147	3.55	angiopoietin 2	chr8p23.1	chr8:6347600-6408170 (-)	1525 ; angiogenesis ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	5102 ; receptor binding ; traceable author statement
206569_at	IL24	NM_006850	3.53	interleukin 24	chr1q32	chr1:205137411-205143832 (+)	6915 ; apoptosis ; traceable author statement ; 6955 ; immune response ; inferred from electronic annotation ; 6915 ; apoptosis ; inferred from electronic annotation	5125 ; cytokine activity ; inferred from electronic annotation
229661_at	SALL4	NM_020436	3.49	sal-like 4 (Drosophila)	chr20q13.13-q13.2	chr20:49833991-49852421 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
241473_at	SULF1	AI624440	3.45	Sulfatase 1	chr8q13.2-q13.3	chr8:70706955-70707350 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 30201 ; heparan sulfate proteoglycan metabolism ; non-traceable author statement	4065 ; arylsulfatase activity ; inferred from direct assay ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8484 ; sulfuric ester hydrolase activity ; inferred from electronic annotation
206026_s_at	TNFAIP6	NM_007115	3.38	tumor necrosis factor, alpha-induced protein 6	chr2q23.3	chr2:151922365-151944799 (+)	6954 ; inflammatory response ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement	5515 ; protein binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; traceable author statement ; 5540 ; hyaluronic acid binding ; inferred from electronic annotation
235371_at		AI452595	3.38	similar to CG9996-PA	chr3	chr3:73099383-73107313 (+)
204463_s_at	EDNRA	AU118882	3.38	endothelin receptor type A	chr4q31.23	chr4:148621579-148685555 (+)	6939 ; smooth muscle contraction ; non-traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; non-traceable author statement ; 7190 ; adenylate cyclase activation ; traceable author statement ; 7202 ; phospholipase C activation ; traceable author statement ; 7204 ; elevation of cytosolic calcium ion concentration ; traceable author statement ; 7585 ; respiratory gaseous exchange ; inferred from sequence or structural similarity ; 8283 ; cell proliferation ; non-traceable author statement ; 15758 ; glucose transport ; inferred from sequence or structural similarity ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 6939 ; smooth muscle contraction ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 1599 ; endothelin-A receptor activity ; non-traceable author statement ; 4435 ; phosphoinositide phospholipase C activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4962 ; endothelin receptor activity ; inferred from electronic annotation ; 4962 ; endothelin receptor activity ; non-traceable author statement
231766_s_at	COL12A1	U73778	3.36	collagen, type XII, alpha 1	chr6q12-q13	chr6:75852578-75972343 (-)	1501 ; skeletal development ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
229459_at	FAM19A5	AV723914	3.35	family with sequence similarity 19 (chemokine (C-C motif)-like), member A5	chr22q13.32	chr22:47533302-47533747 (+)
204619_s_at	CSPG2	BF590263	3.34	chondroitin sulfate proteoglycan 2 (versican)	chr5q14.3	chr5:82803234-82913877 (+)	7275 ; development ; traceable author statement ; 8037 ; cell recognition ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5529 ; sugar binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; traceable author statement ; 5540 ; hyaluronic acid binding ; inferred from electronic annotation ; 5539 ; glycosaminoglycan binding ; traceable author statement
239580_at		BF724601	3.33	CDNA clone IMAGE:5302158	chr4q31.3-q33|4q31.1-q31.2	chr4:156875444-156876254 (+)
201148_s_at	TIMP3	AW338933	3.32	TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory)	chr22q12.1-q13.2|22q12.3	chr22:31526807-31589030 (+)	7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 7600 ; sensory perception ; inferred from electronic annotation ; 7601 ; visual perception ; inferred from electronic annotation ; 8624 ; induction of apoptosis by extracellular signals ; non-traceable author statement	4857 ; enzyme inhibitor activity ; inferred from electronic annotation ; 8191 ; metalloendopeptidase inhibitor activity ; inferred from electronic annotation ; 8191 ; metalloendopeptidase inhibitor activity ; not recorded
235182_at	C20orf82	AI816793	3.31	chromosome 20 open reading frame 82	chr20p12.1	chr20:13228345-13229298 (+)
218839_at	HEY1	NM_012258	3.30	hairy/enhancer-of-split related with YRPW motif 1	chr8q21	chr8:80838819-80842477 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7399 ; nervous system development ; traceable author statement ; 9887 ; organ morphogenesis ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation ; 30528 ; transcription regulator activity ; inferred from electronic annotation ; 3677 ; DNA binding ; traceable author statement
202766_s_at	FBN1	NM_000138	3.26	fibrillin 1 (Marfan syndrome)	chr15q21.1	chr15:46489562-46724391 (-)	1501 ; skeletal development ; traceable author statement ; 7275 ; development ; traceable author statement ; 7601 ; visual perception ; traceable author statement ; 7596 ; blood coagulation ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; traceable author statement ; 5509 ; calcium ion binding ; traceable author statement ; 5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 4888 ; transmembrane receptor activity ; inferred from electronic annotation
231928_at	HES2	AK023754	3.10	hairy and enhancer of split 2 (Drosophila)	chr1p36.31-p36.11	chr1:6397881-6401325 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 30528 ; transcription regulator activity ; inferred from electronic annotation
222108_at		AC_004010	3.09	adhesion molecule with Ig-like domain 2	chr12q13.11	chr12:45756522-45759052 (-)	7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from sequence or structural similarity ; 7157 ; heterophilic cell adhesion ; inferred from sequence or structural similarity ; 43069 ; negative regulation of programmed cell death ; inferred from sequence or structural similarity	5515 ; protein binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from electronic annotation
230311_s_at	PRDM6	AF272898	3.08	PR domain containing 6	chr5q23.2	chr5:122452711-122551595 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
205802_at	TRPC1	NM_003304	3.05	transient receptor potential cation channel, subfamily C, member 1	chr3q22-q24	chr3:143925955-144009420 (+)	6812 ; cation transport ; inferred from electronic annotation ; 6816 ; calcium ion transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 6811 ; ion transport ; inferred from electronic annotation ; 6816 ; calcium ion transport ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 15279 ; store-operated calcium channel activity ; traceable author statement ; 5216 ; ion channel activity ; inferred from electronic annotation ; 5261 ; cation channel activity ; inferred from electronic annotation ; 5262 ; calcium channel activity ; inferred from electronic annotation ; 5262 ; calcium channel activity ; traceable author statement
224694_at	ANTXR1	AF279145	3.03	anthrax toxin receptor 1	chr2p13.1	chr2:69158040-69329961 (+)		4872 ; receptor activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
209708_at	MOXD1	AY007239	3.02	monooxygenase, DBH-like 1	chr6q23.1-23.3	chr6:132658900-132737897 (-)	6548 ; histidine catabolism ; inferred from electronic annotation ; 6584 ; catecholamine metabolism ; inferred from electronic annotation	4497 ; monooxygenase activity ; inferred from electronic annotation ; 4500 ; dopamine beta-monooxygenase activity ; inferred from electronic annotation ; 5507 ; copper ion binding ; inferred from electronic annotation
203083_at	THBS2	NM_003247	3.02	thrombospondin 2	chr6q27	chr6:169357807-169396053 (-)	7155 ; cell adhesion ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; traceable author statement ; 8201 ; heparin binding ; inferred from electronic annotation
203438_at	STC2	AI435828	2.97	stanniocalcin 2	chr5q35.2	chr5:172674331-172688041 (-)	7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 7584 ; response to nutrient ; traceable author statement	5179 ; hormone activity ; traceable author statement ; 5179 ; hormone activity ; inferred from electronic annotation
206025_s_at	TNFAIP6	AW188198	2.96	tumor necrosis factor, alpha-induced protein 6	chr2q23.3	chr2:151922351-151944799 (+)	6954 ; inflammatory response ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement	5515 ; protein binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; traceable author statement ; 5540 ; hyaluronic acid binding ; inferred from electronic annotation
228507_at	PDE3A	AI742043	2.95	Phosphodiesterase 3A, cGMP-inhibited	chr12	chr12:20727647-20728300 (+)	6629 ; lipid metabolism ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation	4119 ; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4114 ; 3,5-cyclic-nucleotide phosphodiesterase activity ; inferred from electronic annotation
204051_s_at	SFRP4	AW089415	2.94	secreted frizzled-related protein 4	chr7p14.1	chr7:37912063-37922943 (-)	16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation
221729_at	COL5A2	AL575735	2.92	collagen, type V, alpha 2	chr2q14-q32	chr2:189604866-189752842 (-)	6817 ; phosphate transport ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; not recorded
207173_x_at	CDH11	D21254	2.90	cadherin 11, type 2, OB-cadherin (osteoblast)	chr16q22.1	chr16:63538185-63713428 (-)	1503 ; ossification ; non-traceable author statement ; 7156 ; homophilic cell adhesion ; non-traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7156 ; homophilic cell adhesion ; inferred from electronic annotation ; 1501 ; skeletal development ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 16337 ; cell-cell adhesion ; non-traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
225285_at	BCAT1	AK025615	2.89	branched chain aminotransferase 1, cytosolic	chr12pter-q12	chr12:24855563-24859009 (-)	82 ; G1/S transition of mitotic cell cycle ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 8283 ; cell proliferation ; traceable author statement ; 9082 ; branched chain family amino acid biosynthesis ; traceable author statement ; 8652 ; amino acid biosynthesis ; inferred from electronic annotation ; 9081 ; branched chain family amino acid metabolism ; inferred from electronic annotation ; 9082 ; branched chain family amino acid biosynthesis ; inferred from electronic annotation	4084 ; branched-chain-amino-acid transaminase activity ; traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4084 ; branched-chain-amino-acid transaminase activity ; inferred from electronic annotation ; 8483 ; transaminase activity ; inferred from electronic annotation
203820_s_at	IMP-3	NM_006547	2.87	IGF-II mRNA-binding protein 3	chr7p11	chr7:23316355-23476504 (-)	6396 ; RNA processing ; traceable author statement ; 6412 ; protein biosynthesis ; traceable author statement ; 9653 ; morphogenesis ; traceable author statement	3676 ; nucleic acid binding ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; traceable author statement
229479_at		AI739132	2.86	Transcribed locus	chr2q35	chr2:216293399-216293964 (+)
201141_at	GPNMB	NM_002510	2.84	glycoprotein (transmembrane) nmb	chr7p15	chr7:23252910-23281250 (+)	8285 ; negative regulation of cell proliferation ; traceable author statement
217762_s_at	RAB31	BE789881	2.83	RAB31, member RAS oncogene family	chr18p11.3	chr18:9698227-9852548 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
219773_at	NOX4	NM_016931	2.83	NADPH oxidase 4	chr11q14.2-q21	chr11:49283842-49358028 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6091 ; generation of precursor metabolites and energy ; traceable author statement	16491 ; oxidoreductase activity ; inferred from electronic annotation ; 166 ; nucleotide binding ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement
202437_s_at	CYP1B1	NM_000104	2.83	cytochrome P450, family 1, subfamily B, polypeptide 1	chr2p21	chr2:38148249-38156796 (-)	1747 ; eye development (sensu Mammalia) ; traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation ; 7601 ; visual perception ; traceable author statement	4497 ; monooxygenase activity ; inferred from electronic annotation ; 5489 ; electron transporter activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50381 ; unspecific monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
204464_s_at	EDNRA	NM_001957	2.79	endothelin receptor type A	chr4q31.23	chr4:148621579-148685555 (+)	6939 ; smooth muscle contraction ; non-traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; non-traceable author statement ; 7190 ; adenylate cyclase activation ; traceable author statement ; 7202 ; phospholipase C activation ; traceable author statement ; 7204 ; elevation of cytosolic calcium ion concentration ; traceable author statement ; 7585 ; respiratory gaseous exchange ; inferred from sequence or structural similarity ; 8283 ; cell proliferation ; non-traceable author statement ; 15758 ; glucose transport ; inferred from sequence or structural similarity ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 6939 ; smooth muscle contraction ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 1599 ; endothelin-A receptor activity ; non-traceable author statement ; 4435 ; phosphoinositide phospholipase C activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4962 ; endothelin receptor activity ; inferred from electronic annotation ; 4962 ; endothelin receptor activity ; non-traceable author statement
232478_at	NR6A1	AU146021	2.78	Nuclear receptor subfamily 6, group A, member 1	chr9q33-q34.1	chr9:126460511-126462749 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7283 ; spermatogenesis ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	3700 ; transcription factor activity ; inferred from electronic annotation ; 3707 ; steroid hormone receptor activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4879 ; ligand-dependent nuclear receptor activity ; traceable author statement
206391_at	RARRES1	NM_002888	2.77	retinoic acid receptor responder (tazarotene induced) 1	chr3q25.32-q25.33	chr3:159905135-159932925 (-)	8285 ; negative regulation of cell proliferation ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation
225710_at		H99792	2.76	CDNA FLJ34013 fis, clone FCBBF2002111	chr3	chr3:180596570-180598807 (-)
212667_at	SPARC	AL575922	2.76	secreted protein, acidic, cysteine-rich (osteonectin)	chr5q31.3-q32	chr5:151021200-151023347 (-)	1503 ; ossification ; traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement	5507 ; copper ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; traceable author statement ; 5518 ; collagen binding ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation
201109_s_at	THBS1	AV726673	2.75	thrombospondin 1	chr15q15	chr15:37660425-37676960 (+)	6928 ; cell motility ; not recorded ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7275 ; development ; traceable author statement ; 7399 ; nervous system development ; not recorded ; 7596 ; blood coagulation ; not recorded	4866 ; endopeptidase inhibitor activity ; traceable author statement ; 4871 ; signal transducer activity ; traceable author statement ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
203878_s_at	MMP11	NM_005940	2.75	matrix metallopeptidase 11 (stromelysin 3)	chr22q11.2|22q11.23	chr22:22445035-22456502 (+)	6508 ; proteolysis ; traceable author statement ; 9653 ; morphogenesis ; not recorded ; 30574 ; collagen catabolism ; inferred from electronic annotation ; 6508 ; proteolysis ; inferred from electronic annotation ; 7275 ; development ; traceable author statement	4249 ; stromelysin 3 activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
227645_at	PIK3R5	BG236366	2.72	phosphoinositide-3-kinase, regulatory subunit 5, p101	chr17p13.1	chr17:8329499-8723684 (-)		16301 ; kinase activity ; inferred from electronic annotation
202497_x_at	SLC2A3	AI631159	2.71	solute carrier family 2 (facilitated glucose transporter), member 3	chr12p13.3	chr12:7963092-7980138 (-)	5975 ; carbohydrate metabolism ; non-traceable author statement ; 8643 ; carbohydrate transport ; inferred from electronic annotation ; 15758 ; glucose transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7283 ; spermatogenesis ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5351 ; sugar porter activity ; inferred from electronic annotation ; 5355 ; glucose transporter activity ; traceable author statement ; 5355 ; glucose transporter activity ; inferred from electronic annotation
215078_at	SOD2	AL050388	2.71	superoxide dismutase 2, mitochondrial	chr6q25.3	chr6:160032020-160034266 (-)	303 ; response to superoxide ; traceable author statement ; 1315 ; age-dependent response to reactive oxygen species ; inferred from mutant phenotype ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from mutant phenotype ; 6801 ; superoxide metabolism ; inferred from direct assay ; 6979 ; response to oxidative stress ; traceable author statement ; 16066 ; cellular defense response (sensu Vertebrata) ; inferred from mutant phenotype ; 6801 ; superoxide metabolism ; inferred from electronic annotation ; 303 ; response to superoxide ; inferred from sequence or structural similarity ; 1315 ; age-dependent response to reactive oxygen species ; inferred from sequence or structural similarity ; 6357 ; regulation of transcription from RNA polymerase II promoter ; inferred from sequence or structural similarity ; 16066 ; cellular defense response (sensu Vertebrata) ; inferred from sequence or structural similarity	8383 ; manganese superoxide dismutase activity ; inferred from direct assay ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4784 ; superoxide dismutase activity ; inferred from electronic annotation
221730_at	COL5A2	NM_000393	2.67	collagen, type V, alpha 2	chr2q14-q32	chr2:189604866-189752842 (-)	6817 ; phosphate transport ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; not recorded
212265_at		AL031781	2.66	quaking homolog, KH domain RNA binding (mouse)	chr6q26-q27	chr6:163756198-163914889 (+)		3676 ; nucleic acid binding ; inferred from electronic annotation
204114_at	NID2	NM_007361	2.65	nidogen 2 (osteonidogen)	chr14q21-q22	chr14:51541277-51605462 (-)	7155 ; cell adhesion ; traceable author statement ; 7160 ; cell-matrix adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 5518 ; collagen binding ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation
204924_at	TLR2	NM_003264	2.64	toll-like receptor 2	chr4q32	chr4:154843487-154845980 (+)	6917 ; induction of apoptosis ; traceable author statement ; 6954 ; inflammatory response ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 6955 ; immune response ; inferred from electronic annotation ; 45087 ; innate immune response ; inferred from electronic annotation ; 6955 ; immune response ; traceable author statement	1875 ; lipopolysaccharide receptor activity ; traceable author statement ; 4888 ; transmembrane receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 42834 ; peptidoglycan binding ; inferred from direct assay ; 51076 ; Gram-positive bacterial binding ; inferred from direct assay ; 4872 ; receptor activity ; inferred from direct assay ; 8329 ; pattern recognition receptor activity ; inferred from direct assay ; 4872 ; receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; traceable author statement
241706_at	CPNE8	AA431782	2.64	copine VIII	chr12q12	chr12:37406427-37585687 (-)
223378_at	GLIS2	AA705182	2.64	GLIS family zinc finger 2	chr16p13.3	chr16:4322260-4329597 (+)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
235438_at		AW162011	2.64	MRNA; cDNA DKFZp686E22185 (from clone DKFZp686E22185)	chr8q21.3	chr8:65665963-65667024 (-)
227566_at	HNT	AW085558	2.62	neurotrimin	chr11q25	chr11:131710908-131711918 (+)	7155 ; cell adhesion ; non-traceable author statement ; 8038 ; neuron recognition ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
242306_at	TPARL	N71463	2.61	TPA regulated locus	chr4q12	chr4:55967505-55968344 (+)
208782_at	FSTL1	BC000055	2.61	follistatin-like 1	chr3q13.33	chr3:121595816-121652515 (-)		5509 ; calcium ion binding ; inferred from electronic annotation ; 8201 ; heparin binding ; traceable author statement ; 8201 ; heparin binding ; inferred from electronic annotation
202291_s_at	MGP	NM_000900	2.59	matrix Gla protein	chr12p13.1-p12.3	chr12:14926094-14930035 (-)	1502 ; cartilage condensation ; traceable author statement ; 1503 ; ossification ; traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 30500 ; regulation of bone mineralization ; inferred from electronic annotation ; 1503 ; ossification ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 51216 ; cartilage development ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8147 ; structural constituent of bone ; traceable author statement ; 5509 ; calcium ion binding ; not recorded
229802_at	WISP1	AA147884	2.58	WNT1 inducible signaling pathway protein 1	chr8	chr8:134312508-134383551 (+)	1558 ; regulation of cell growth ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; traceable author statement ; 16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation ; 5520 ; insulin-like growth factor binding ; inferred from electronic annotation
225034_at	SIAT4A	AI885015	2.57	hypothetical protein LOC286167	chr8q24.22	chr8:134536273-134539258 (-)
228275_at		AI200555	2.56	Full-length cDNA clone CS0DH004YM21 of T cells (Jurkat cell line) of Homo sapiens (human)	chr3	chr3:184648172-184656122 (+)
213139_at	SNAI2	AI572079	2.56	snail homolog 2 (Drosophila)	chr8q11	chr8:49992879-49996705 (-)	122 ; negative regulation of transcription from RNA polymerase II promoter ; traceable author statement ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7499 ; ectoderm and mesoderm interaction ; traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
226517_at	BCAT1; BCT1; ECA39; MECA39	AL390172	2.56	branched chain aminotransferase 1, cytosolic	chr12pter-q12	chr12:24858870-24861861 (-)	82 ; G1/S transition of mitotic cell cycle ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation ; 8283 ; cell proliferation ; traceable author statement ; 9082 ; branched chain family amino acid biosynthesis ; traceable author statement ; 8652 ; amino acid biosynthesis ; inferred from electronic annotation ; 9081 ; branched chain family amino acid metabolism ; inferred from electronic annotation ; 9082 ; branched chain family amino acid biosynthesis ; inferred from electronic annotation	4084 ; branched-chain-amino-acid transaminase activity ; traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4084 ; branched-chain-amino-acid transaminase activity ; inferred from electronic annotation ; 8483 ; transaminase activity ; inferred from electronic annotation
210095_s_at	IGFBP3	M31159	2.55	insulin-like growth factor binding protein 3	chr7p13-p12	chr7:45918482-45927364 (-)	1558 ; regulation of cell growth ; inferred from electronic annotation ; 9968 ; negative regulation of signal transduction ; non-traceable author statement ; 43065 ; positive regulation of apoptosis ; inferred from mutant phenotype ; 45663 ; positive regulation of myoblast differentiation ; inferred from direct assay	5520 ; insulin-like growth factor binding ; non-traceable author statement ; 8160 ; protein tyrosine phosphatase activator activity ; inferred from direct assay ; 46872 ; metal ion binding ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5520 ; insulin-like growth factor binding ; inferred from electronic annotation ; 19838 ; growth factor binding ; inferred from electronic annotation
226777_at	ADAM12	AA147933	2.55	ADAM metallopeptidase domain 12 (meltrin alpha)	chr10	chr10:127690949-127692767 (-)	6508 ; proteolysis ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7229 ; integrin-mediated signaling pathway ; inferred from electronic annotation ; 7520 ; myoblast fusion ; traceable author statement	4222 ; metalloendopeptidase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8237 ; metallopeptidase activity ; traceable author statement
201617_x_at	CALD1	NM_004342	2.55	caldesmon 1	chr7q33	chr7:134114940-134304637 (+)	6936 ; muscle contraction ; inferred from electronic annotation ; 7517 ; muscle development ; inferred from electronic annotation	3779 ; actin binding ; traceable author statement ; 5516 ; calmodulin binding ; traceable author statement ; 5523 ; tropomyosin binding ; traceable author statement ; 17022 ; myosin binding ; inferred from electronic annotation ; 3779 ; actin binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation
205100_at	GFPT2	NM_005110	2.54	glutamine-fructose-6-phosphate transaminase 2	chr5q34-q35	chr5:179660305-179712921 (-)	5975 ; carbohydrate metabolism ; inferred from electronic annotation ; 6002 ; fructose 6-phosphate metabolism ; traceable author statement ; 6112 ; energy reserve metabolism ; traceable author statement ; 6541 ; glutamine metabolism ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 16051 ; carbohydrate biosynthesis ; inferred from electronic annotation	4360 ; glutamine-fructose-6-phosphate transaminase (isomerizing) activity ; traceable author statement ; 5529 ; sugar binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4360 ; glutamine-fructose-6-phosphate transaminase (isomerizing) activity ; inferred from electronic annotation ; 8483 ; transaminase activity ; inferred from electronic annotation
203477_at	COL15A1	NM_001855	2.54	collagen, type XV, alpha 1	chr9q21-q22	chr9:100746075-100872893 (+)	1525 ; angiogenesis ; inferred from electronic annotation ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
202620_s_at	PLOD2	NM_000935	2.52	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2	chr3q23-q24	chr3:147269921-147361466 (-)	6464 ; protein modification ; traceable author statement ; 19538 ; protein metabolism ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 8475 ; procollagen-lysine 5-dioxygenase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 16702 ; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen ; inferred from electronic annotation ; 31418 ; L-ascorbic acid binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8475 ; procollagen-lysine 5-dioxygenase activity ; inferred from electronic annotation ; 16706 ; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors ; inferred from electronic annotation
202499_s_at	SLC2A3	NM_006931	2.52	solute carrier family 2 (facilitated glucose transporter), member 3	chr12p13.3	chr12:7963093-7980138 (-)	5975 ; carbohydrate metabolism ; non-traceable author statement ; 8643 ; carbohydrate transport ; inferred from electronic annotation ; 15758 ; glucose transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 7283 ; spermatogenesis ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5351 ; sugar porter activity ; inferred from electronic annotation ; 5355 ; glucose transporter activity ; traceable author statement ; 5355 ; glucose transporter activity ; inferred from electronic annotation
202363_at	SPOCK	AF231124	2.51	sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican)	chr5q31	chr5:136338890-136862148 (-)	6928 ; cell motility ; traceable author statement ; 7155 ; cell adhesion ; traceable author statement ; 7275 ; development ; traceable author statement ; 7399 ; nervous system development ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation
226695_at	PRRX1	AA775472	2.51	paired related homeobox 1	chr1q24	chr1:168974564-168975165 (+)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3713 ; transcription coactivator activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
205227_at	IL1RAP	NM_002182	2.51	interleukin 1 receptor accessory protein	chr3q28	chr3:191714584-191851995 (+)	6461 ; protein complex assembly ; traceable author statement ; 6954 ; inflammatory response ; traceable author statement ; 6955 ; immune response ; traceable author statement	4888 ; transmembrane receptor activity ; inferred from electronic annotation ; 4908 ; interleukin-1 receptor activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 4872 ; receptor activity ; inferred from electronic annotation ; 4871 ; signal transducer activity ; traceable author statement
229218_at	COL1A2	AA628535	2.50	Collagen, type I, alpha 2	chr7q22.1	chr7:93888980-93889820 (+)	1501 ; skeletal development ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; non-traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 8147 ; structural constituent of bone ; not recorded ; 5198 ; structural molecule activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; non-traceable author statement
225999_at	KIAA1238	AI743612	2.49	family with sequence similarity 80, member B	chr12p13.31	chr12:8741899-8821054 (+)	6464 ; protein modification ; inferred from electronic annotation ; 7046 ; ribosome biogenesis ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
226372_at	CHST11	AI123348	2.48	Carbohydrate (chondroitin 4) sulfotransferase 11	chr12q	chr12:103677422-103679920 (+)	5975 ; carbohydrate metabolism ; inferred from electronic annotation ; 30206 ; chondroitin sulfate biosynthesis ; inferred from direct assay	1537 ; N-acetylgalactosamine 4-O-sulfotransferase activity ; inferred from direct assay ; 16740 ; transferase activity ; inferred from electronic annotation ; 47756 ; chondroitin 4-sulfotransferase activity ; inferred from direct assay ; 47756 ; chondroitin 4-sulfotransferase activity ; inferred from electronic annotation
201310_s_at	C5orf13	NM_004772	2.46	chromosome 5 open reading frame 13	chr5q22.1	chr7:23486743-23488710 (+)
203695_s_at	DFNA5	NM_004403	2.44	deafness, autosomal dominant 5	chr7p15	chr7:24704499-24763888 (-)	7605 ; sensory perception of sound ; traceable author statement ; 7605 ; sensory perception of sound ; inferred from electronic annotation
225664_at	COL12A1	AA788946	2.44	collagen, type XII, alpha 1	chr6q12-q13	chr6:75850761-75851940 (-)	1501 ; skeletal development ; traceable author statement ; 6817 ; phosphate transport ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation	5198 ; structural molecule activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
219454_at	EGFL6	NM_015507	2.43	EGF-like-domain, multiple 6	chrXp22	chrX:13497661-13561614 (+)	7049 ; cell cycle ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5178 ; integrin binding ; traceable author statement
208394_x_at	ESM1	NM_007036	2.43	endothelial cell-specific molecule 1	chr5q11.2	chr5:54309452-54317164 (-)	1558 ; regulation of cell growth ; inferred from electronic annotation	5515 ; protein binding ; non-traceable author statement ; 5520 ; insulin-like growth factor binding ; inferred from electronic annotation ; 8083 ; growth factor activity ; non-traceable author statement
218559_s_at	MAFB	NM_005461	2.42	v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)	chr20q11.2-q13.1	chr20:38747932-38750977 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7423 ; sensory organ development ; traceable author statement	3677 ; DNA binding ; inferred from electronic annotation
201616_s_at	CALD1	AL577531	2.42	caldesmon 1	chr7q33	chr7:134114915-134305231 (+)	6936 ; muscle contraction ; inferred from electronic annotation ; 7517 ; muscle development ; inferred from electronic annotation	3779 ; actin binding ; traceable author statement ; 5516 ; calmodulin binding ; traceable author statement ; 5523 ; tropomyosin binding ; traceable author statement ; 17022 ; myosin binding ; inferred from electronic annotation ; 3779 ; actin binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation
214957_at	LOC81569	BF594459	2.42	actin-like 8	chr1p36.2-p35	chr1:18022065-18026143 (+)		5515 ; protein binding ; inferred from electronic annotation
226865_at		AW130600	2.40	MRNA; cDNA DKFZp564O0862 (from clone DKFZp564O0862)	chr10	chr10:20615775-20617972 (+)
225978_at	KIAA1238	AW409794	2.40	family with sequence similarity 80, member B	chr12p13.31	chr12:8741899-8821054 (+)	6464 ; protein modification ; inferred from electronic annotation ; 7046 ; ribosome biogenesis ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation
235537_at	OCIAD1	AI377685	2.40	OCIA domain containing 1	chr4p11	chr4:48528224-48529127 (+)
228224_at	PRELP	AA573140	2.40	proline/arginine-rich end leucine-rich repeat protein	chr1q32	chr1:201724661-201725366 (+)	1501 ; skeletal development ; traceable author statement	5201 ; extracellular matrix structural constituent ; traceable author statement
232458_at	COL3A1	AU146808	2.40	Collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)	chr2q31	chr2:189550055-189551727 (+)	6817 ; phosphate transport ; inferred from electronic annotation ; 8015 ; circulation ; traceable author statement ; 9887 ; organ morphogenesis ; not recorded	5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation
229764_at	FLJ41238	AW629527	2.39	family with sequence similarity 79, member B	chr3q28	chr3:190439304-190521544 (+)
205648_at	WNT2	NM_003391	2.39	wingless-type MMTV integration site family member 2	chr7q31	chr7:116704517-116750579 (-)	7223 ; frizzled-2 signaling pathway ; inferred from electronic annotation ; 7275 ; development ; non-traceable author statement ; 7275 ; development ; inferred from electronic annotation ; 16055 ; Wnt receptor signaling pathway ; inferred from electronic annotation	4871 ; signal transducer activity ; inferred from electronic annotation ; 5201 ; extracellular matrix structural constituent ; non-traceable author statement
202619_s_at	PLOD2	AI754404	2.38	procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2	chr3q23-q24	chr3:147269916-147361648 (-)	6464 ; protein modification ; traceable author statement ; 19538 ; protein metabolism ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 8475 ; procollagen-lysine 5-dioxygenase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 16702 ; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen ; inferred from electronic annotation ; 31418 ; L-ascorbic acid binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8475 ; procollagen-lysine 5-dioxygenase activity ; inferred from electronic annotation ; 16706 ; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors ; inferred from electronic annotation
217764_s_at	RAB31	AF183421	2.38	RAB31, member RAS oncogene family	chr18p11.3	chr18:9698264-9852547 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
223730_at	GPC6	AF111178	2.37	glypican 6	chr13q32	chr13:92677095-93853813 (+)
204604_at	PFTK1	NM_012395	2.37	PFTAIRE protein kinase 1	chr7q21-q22	chr7:90176647-90677840 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
214770_at	MSR1	AI299239	2.37	macrophage scavenger receptor 1	chr8p22	chr8:16009655-16079874 (-)	6817 ; phosphate transport ; inferred from electronic annotation ; 6898 ; receptor mediated endocytosis ; traceable author statement ; 6897 ; endocytosis ; inferred from electronic annotation ; 6898 ; receptor mediated endocytosis ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; traceable author statement ; 5319 ; lipid transporter activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; inferred from electronic annotation
225481_at	C14orf31	AL040051	2.36	FERM domain containing 6	chr14q22.1	chr14:51256720-51267195 (+)		5488 ; binding ; inferred from electronic annotation
236297_at	PLXDC2	AI420817	2.36	Chromosome 10 open reading frame 112	chr10	chr10:20610171-20610605 (+)
204682_at	LTBP2	NM_000428	2.35	latent transforming growth factor beta binding protein 2	chr14q24	chr14:74036210-74148787 (-)	74 ; regulation of progression through cell cycle ; non-traceable author statement ; 6605 ; protein targeting ; traceable author statement ; 6858 ; extracellular transport ; not recorded ; 7179 ; transforming growth factor beta receptor signaling pathway ; traceable author statement ; 9306 ; protein secretion ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 19838 ; growth factor binding ; inferred from electronic annotation ; 5515 ; protein binding ; traceable author statement
219410_at	FLJ10134	NM_018004	2.35	transmembrane protein 45A	chr3q12.2	chr3:101694152-101778975 (+)
212372_at	MYH10	AK026977	2.35	myosin, heavy polypeptide 10, non-muscle	chr17p13	chr17:8318254-8348927 (-)	910 ; cytokinesis ; non-traceable author statement ; 8360 ; regulation of cell shape ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3774 ; motor activity ; inferred from electronic annotation ; 3779 ; actin binding ; non-traceable author statement ; 5516 ; calmodulin binding ; inferred from electronic annotation ; 5524 ; ATP binding ; non-traceable author statement ; 3779 ; actin binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction
205207_at	IL6	NM_000600	2.34	interleukin 6 (interferon, beta 2)	chr7p21	chr7:22733344-22738141 (+)	6953 ; acute-phase response ; inferred from electronic annotation ; 6959 ; humoral immune response ; traceable author statement ; 7166 ; cell surface receptor linked signal transduction ; traceable author statement ; 7267 ; cell-cell signaling ; non-traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 8285 ; negative regulation of cell proliferation ; traceable author statement ; 6955 ; immune response ; inferred from electronic annotation ; 7267 ; cell-cell signaling ; traceable author statement ; 6959 ; humoral immune response ; inferred from sequence or structural similarity ; 7166 ; cell surface receptor linked signal transduction ; inferred from sequence or structural similarity ; 7267 ; cell-cell signaling ; inferred from sequence or structural similarity ; 8284 ; positive regulation of cell proliferation ; inferred from sequence or structural similarity ; 8285 ; negative regulation of cell proliferation ; inferred from sequence or structural similarity	5125 ; cytokine activity ; inferred from electronic annotation ; 5138 ; interleukin-6 receptor binding ; non-traceable author statement ; 5138 ; interleukin-6 receptor binding ; inferred from electronic annotation ; 8083 ; growth factor activity ; inferred from electronic annotation ; 5138 ; interleukin-6 receptor binding ; traceable author statement ; 8083 ; growth factor activity ; traceable author statement ; 5138 ; interleukin-6 receptor binding ; inferred from sequence or structural similarity ; 8083 ; growth factor activity ; inferred from sequence or structural similarity
242790_at	EAP30	AA935515	2.34	SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)	chr17q21.32	chr17:44363750-44365425 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation
223475_at	LOC83690	AF142573	2.33	cysteine-rich secretory protein LCCL domain containing 1	chr8q21.11	chr8:76059666-76108087 (+)
226997_at		W74476	2.33	CDNA FLJ10196 fis, clone HEMBA1004776	chr5	chr5:33559397-33561243 (-)
227486_at	NT5E	AI086864	2.32	5-nucleotidase, ecto (CD73)	chr6q14-q21	chr6:86216521-86218889 (+)	6259 ; DNA metabolism ; traceable author statement ; 9166 ; nucleotide catabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 8253 ; 5-nucleotidase activity ; traceable author statement ; 16788 ; hydrolase activity, acting on ester bonds ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8253 ; 5-nucleotidase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
238623_at	MAP3K4	AI633559	2.31	Mitogen-activated protein kinase kinase kinase 4	chr6	chr6:161331339-161332012 (-)	186 ; activation of MAPKK activity ; traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 6950 ; response to stress ; traceable author statement ; 7254 ; JNK cascade ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4709 ; MAP kinase kinase kinase activity ; traceable author statement ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
201261_x_at	BGN	BC002416	2.29	biglycan	chrXq28	chrX:152413646-152428198 (+)		5201 ; extracellular matrix structural constituent ; non-traceable author statement
228948_at	EPHA4	T15545	2.28	EPH receptor A4	chr2q36.1	chr2:221991669-221993318 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 5003 ; ephrin receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; traceable author statement
243908_at	ZNF638	AI308174	2.28	Zinc finger protein 638	chr2p13.2-p13.1	chr2:71502490-71502936 (+)	8380 ; RNA splicing ; traceable author statement	3690 ; double-stranded DNA binding ; traceable author statement ; 3723 ; RNA binding ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation
212344_at	SULF1	AW043713	2.26	sulfatase 1	chr8q13.2-q13.3	chr8:70576662-70735701 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation ; 30201 ; heparan sulfate proteoglycan metabolism ; non-traceable author statement	4065 ; arylsulfatase activity ; inferred from direct assay ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8484 ; sulfuric ester hydrolase activity ; inferred from electronic annotation
215049_x_at	CD163	Z22969	2.25	CD163 antigen	chr12p13.3	chr12:7515038-7547639 (-)	19735 ; antimicrobial humoral response (sensu Vertebrata) ; traceable author statement	5044 ; scavenger receptor activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; non-traceable author statement ; 5044 ; scavenger receptor activity ; traceable author statement
218834_s_at	HSPA5BP1	NM_017870	2.25	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) binding protein 1	chr11q12.2	chr11:60448521-60461206 (+)
211980_at	COL4A1	AI922605	2.25	collagen, type IV, alpha 1	chr13q34	chr13:109599315-109757375 (-)	6817 ; phosphate transport ; inferred from electronic annotation	5201 ; extracellular matrix structural constituent ; inferred from electronic annotation ; 5198 ; structural molecule activity ; inferred from electronic annotation
201280_s_at	DAB2	NM_001343	2.25	disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)	chr5p13	chr5:39408502-39460703 (-)	8283 ; cell proliferation ; traceable author statement
209906_at	C3AR1	U62027	2.24	complement component 3a receptor 1	chr12p13.31	chr12:8102178-8110276 (-)	6928 ; cell motility ; not recorded ; 6935 ; chemotaxis ; inferred from electronic annotation ; 6939 ; smooth muscle contraction ; not recorded ; 6954 ; inflammatory response ; traceable author statement ; 6968 ; cellular defense response ; not recorded ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7204 ; elevation of cytosolic calcium ion concentration ; inferred from genetic interaction ; 7600 ; sensory perception ; inferred from electronic annotation ; 8015 ; circulation ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation ; 7204 ; elevation of cytosolic calcium ion concentration ; traceable author statement	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4435 ; phosphoinositide phospholipase C activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 4876 ; complement component C3a receptor activity ; traceable author statement ; 4943 ; C3a anaphylatoxin receptor activity ; traceable author statement ; 4930 ; G-protein coupled receptor activity ; inferred from genetic interaction ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4942 ; anaphylatoxin receptor activity ; inferred from electronic annotation ; 4943 ; C3a anaphylatoxin receptor activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; traceable author statement
216858_x_at		AL080112	2.23		chr10	chr10:104050674-104052195 (+)
221872_at	RARRES1	AI669229	2.23	retinoic acid receptor responder (tazarotene induced) 1	chr3q25.32-q25.33	chr3:159897585-159911332 (-)	8285 ; negative regulation of cell proliferation ; traceable author statement	4872 ; receptor activity ; inferred from electronic annotation
206994_at	CST4	NM_001899	2.23	cystatin S	chr20p11.21	chr20:23614276-23617662 (-)		4869 ; cysteine protease inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4869 ; cysteine protease inhibitor activity ; not recorded
241985_at	JMY	AI814405	2.22	junction-mediating and regulatory protein	chr5q14.1	chr5:78653188-78653704 (+)
231987_at		AW081196	2.22	Hypothetical protein DKFZp586C0721	chr5q33.1	chr5:148782665-148788502 (+)
230728_at		BF516305	2.22	Transcribed locus	chr7	chr7:30016730-30017225 (-)
235411_at	PGBD1	BE883300	2.21	piggyBac transposable element derived 1	chr6p22.1	chr6:28376521-28377567 (+)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; inferred from electronic annotation
230071_at	SEP11	AI333326	2.21	Septin 11	chr4q21.1	chr4:78171858-78173335 (+)	7049 ; cell cycle ; inferred from electronic annotation ; 51291 ; protein heterooligomerization ; inferred from direct assay ; 51301 ; cell division ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5525 ; GTP binding ; inferred from electronic annotation
221942_s_at	GUCY1A3	AI719730	2.21	guanylate cyclase 1, soluble, alpha 3	chr4q31.3-q33|4q31.1-q31.2	chr4:156857818-156872180 (+)	6182 ; cGMP biosynthesis ; inferred from electronic annotation ; 7263 ; nitric oxide mediated signal transduction ; traceable author statement ; 8015 ; circulation ; traceable author statement ; 7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 9190 ; cyclic nucleotide biosynthesis ; inferred from electronic annotation	4383 ; guanylate cyclase activity ; traceable author statement ; 4872 ; receptor activity ; traceable author statement ; 4383 ; guanylate cyclase activity ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 16849 ; phosphorus-oxygen lyase activity ; inferred from electronic annotation
228298_at	MGC16044	BF056901	2.20	hypothetical protein MGC16044	chr12q13.11	chr12:45916098-45916710 (+)
229530_at		BF002625	2.20	Transcribed locus	chr4q31.3-q33|4q31.1-q31.2	chr4:156873364-156874431 (+)
203140_at	BCL6	NM_001706	2.20	B-cell CLL/lymphoma 6 (zinc finger protein 51) ; B-cell CLL/lymphoma 6 (zinc finger protein 51)	chr3q27	chr3:188921865-188946169 (-)	122 ; negative regulation of transcription from RNA polymerase II promoter ; not recorded ; 6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; traceable author statement ; 6954 ; inflammatory response ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3700 ; transcription factor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation
222088_s_at	SLC2A14	AA778684	2.20	solute carrier family 2 (facilitated glucose transporter), member 3 ; solute carrier family 2 (facilitated glucose transporter), member 14	chr12p13.3	chr12:7856374-7857106 (-)	5975 ; carbohydrate metabolism ; non-traceable author statement ; 8643 ; carbohydrate transport ; inferred from electronic annotation ; 15758 ; glucose transport ; traceable author statement ; 7283 ; spermatogenesis ; inferred from electronic annotation ; 30154 ; cell differentiation ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	5215 ; transporter activity ; inferred from electronic annotation ; 5351 ; sugar porter activity ; inferred from electronic annotation ; 5355 ; glucose transporter activity ; traceable author statement ; 5355 ; glucose transporter activity ; inferred from electronic annotation
220617_s_at	ZNF532	NM_018181	2.20	zinc finger protein 532	chr18q21.32	chr10:79162679-79167415 (+)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
218404_at	SNX10	NM_013322	2.19	sorting nexin 10	chr7p15.2	chr7:26299198-26380463 (+)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation
225345_s_at	FBXO32	AU155376	2.19	F-box protein 32	chr8	chr8:124579309-124582776 (-)	6512 ; ubiquitin cycle ; inferred from electronic annotation
223599_at	TRIM6	AF220030	2.19	tripartite motif-containing 6	chr11p15.4	chr11:5573931-5590757 (+)	16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
237052_x_at		BE220828	2.18		chr2q37.1	chr2:233433086-233433529 (+)
217763_s_at	RAB31	NM_006868	2.18	RAB31, member RAS oncogene family	chr18p11.3	chr18:9698353-9849586 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation ; 15031 ; protein transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
214806_at	BICD1	U90030	2.16	bicaudal D homolog 1 (Drosophila)	chr12	chr12:32378717-32382853 (+)	6396 ; RNA processing ; traceable author statement ; 8298 ; intracellular mRNA localization ; non-traceable author statement ; 9653 ; morphogenesis ; traceable author statement	5200 ; structural constituent of cytoskeleton ; traceable author statement
235733_at		AW043921	2.15	Transcribed locus	chr3p13	chr3:73108241-73108890 (+)
213358_at	KIAA0802	AB018345	2.14	KIAA0802	chr18p11.22	chr18:8773685-8822776 (+)
202686_s_at	AXL	NM_021913	2.14	AXL receptor tyrosine kinase	chr19q13.1	chr19:46416662-46459510 (+)	74 ; regulation of progression through cell cycle ; traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7165 ; signal transduction ; traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
204589_at	ARK5	NM_014840	2.14	NUAK family, SNF1-like kinase, 1	chr12q23.3	chr12:104981254-105057941 (-)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
212607_at	AKT3	N32526	2.13	v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)	chr1q43-q44	chr1:241729648-241733354 (-)	6468 ; protein amino acid phosphorylation ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; traceable author statement
213553_x_at	APOC1	W79394	2.13	apolipoprotein C-I	chr19q13.2	chr19:50104471-50126417 (+)	6629 ; lipid metabolism ; traceable author statement ; 6869 ; lipid transport ; inferred from electronic annotation ; 42157 ; lipoprotein metabolism ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5319 ; lipid transporter activity ; inferred from electronic annotation
218854_at	SART2	NM_013352	2.13	squamous cell carcinoma antigen recognized by T cells 2	chr6q22	chr6:116798881-116866133 (+)
211656_x_at	HLA-DQB1	M32577	2.13	major histocompatibility complex, class II, DQ beta 1 ; major histocompatibility complex, class II, DQ beta 1	chr6p21.3	chr6:32735641-32742330 (-)	6955 ; immune response ; inferred from electronic annotation ; 6955 ; immune response ; non-traceable author statement ; 19884 ; antigen presentation, exogenous antigen ; inferred from electronic annotation ; 19886 ; antigen processing, exogenous antigen via MHC class II ; inferred from electronic annotation	45012 ; MHC class II receptor activity ; inferred from electronic annotation ; 45012 ; MHC class II receptor activity ; non-traceable author statement
202435_s_at	CYP1B1	AU154504	2.13	cytochrome P450, family 1, subfamily B, polypeptide 1	chr2p21	chr2:38148155-38157214 (-)	1747 ; eye development (sensu Mammalia) ; traceable author statement ; 6118 ; electron transport ; inferred from electronic annotation ; 7601 ; visual perception ; traceable author statement	4497 ; monooxygenase activity ; inferred from electronic annotation ; 5489 ; electron transporter activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; traceable author statement ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 50381 ; unspecific monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
232615_at	FLJ39739	AA632758	2.12	FLJ39739 protein	chr1q12	chr1:147851471-147853491 (+)
214803_at		BF344237	2.12	CDNA clone IMAGE:4152983	chr5	chr5:31362556-31365008 (+)
243882_at		AA740831	2.12		chr6	chr6:32730807-32731501 (-)
204620_s_at	CSPG2	NM_004385	2.11	chondroitin sulfate proteoglycan 2 (versican)	chr5q14.3	chr5:82803338-82912737 (+)	7275 ; development ; traceable author statement ; 8037 ; cell recognition ; traceable author statement ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement	5509 ; calcium ion binding ; inferred from electronic annotation ; 5529 ; sugar binding ; inferred from electronic annotation ; 5540 ; hyaluronic acid binding ; traceable author statement ; 5540 ; hyaluronic acid binding ; inferred from electronic annotation ; 5539 ; glycosaminoglycan binding ; traceable author statement
211726_s_at	FMO2	BC005894	2.11	flavin containing monooxygenase 2 ; flavin containing monooxygenase 2	chr1q23-q25	chr1:169421064-169444955 (+)	6118 ; electron transport ; inferred from electronic annotation	287 ; magnesium ion binding ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; traceable author statement ; 4499 ; dimethylaniline monooxygenase (N-oxide-forming) activity ; inferred from electronic annotation ; 50660 ; FAD binding ; inferred from electronic annotation ; 50661 ; NADP binding ; inferred from electronic annotation ; 4497 ; monooxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
205479_s_at	PLAU	NM_002658	2.10	plasminogen activator, urokinase	chr10q24	chr10:75340940-75347258 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 6508 ; proteolysis ; traceable author statement ; 6935 ; chemotaxis ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7596 ; blood coagulation ; inferred from electronic annotation ; 42730 ; fibrinolysis ; inferred from electronic annotation ; 7596 ; blood coagulation ; not recorded	4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8243 ; plasminogen activator activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
233039_at	SPRED1	AK021887	2.10	Sprouty-related, EVH1 domain containing 1	chr15q14	chr15:36412298-36413591 (+)	188 ; inactivation of MAPK activity ; inferred from sequence or structural similarity ; 7275 ; development ; inferred from electronic annotation ; 9966 ; regulation of signal transduction ; inferred from electronic annotation	5173 ; stem cell factor receptor binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
227276_at	PLXDC2	AI264121	2.09	plexin domain containing 2	chr10p12.32-p12.31	chr10:20505995-20609292 (+)	7275 ; development ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation
224733_at	CKLFSF3	AL574900	2.09	chemokine-like factor superfamily 3	chr16q21-q22.1	chr16:65195848-65205291 (+)	6935 ; chemotaxis ; inferred from electronic annotation ; 7600 ; sensory perception ; inferred from electronic annotation	5125 ; cytokine activity ; inferred from electronic annotation
203549_s_at	LPL	NM_000237	2.08	lipoprotein lipase	chr8p22	chr8:19841057-19869049 (+)	6631 ; fatty acid metabolism ; not recorded ; 8015 ; circulation ; traceable author statement ; 16042 ; lipid catabolism ; inferred from electronic annotation ; 6629 ; lipid metabolism ; inferred from electronic annotation	4465 ; lipoprotein lipase activity ; traceable author statement ; 5319 ; lipid transporter activity ; inferred from electronic annotation ; 8201 ; heparin binding ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4465 ; lipoprotein lipase activity ; inferred from electronic annotation ; 8201 ; heparin binding ; inferred from electronic annotation
214807_at		AI278204	2.08	MRNA; cDNA DKFZp564O0862 (from clone DKFZp564O0862)	chr10	chr10:20613600-20615774 (+)
225021_at	ZNF532	AA861416	2.07	zinc finger protein 532	chr18q21.32	chr18:54683253-54804689 (+)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
226271_at	GDAP1	N46350	2.07	Ganglioside-induced differentiation-associated protein 1	chr8q21.11	chr8:75439208-75441669 (+)
225464_at	FRMD6	N30138	2.06	FERM domain containing 6	chr14q22.1	chr14:51256720-51267195 (+)		5488 ; binding ; inferred from electronic annotation
238852_at	PRRX1	AA424567	2.06	Paired related homeobox 1	chr1q24	chr1:168964205-168964777 (+)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3713 ; transcription coactivator activity ; traceable author statement ; 3677 ; DNA binding ; inferred from electronic annotation
214761_at	ZNF423	AW149417	2.06	zinc finger protein 423	chr16q12	chr16:48082021-48322225 (-)		3676 ; nucleic acid binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
213135_at	TIAM1	U90902	2.06	T-cell lymphoma invasion and metastasis 1	chr21q22.1|21q22.11	chr21:31412606-31414423 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 7165 ; signal transduction ; inferred from electronic annotation	5057 ; receptor signaling protein activity ; inferred from electronic annotation ; 5089 ; Rho guanyl-nucleotide exchange factor activity ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation ; 5085 ; guanyl-nucleotide exchange factor activity ; inferred from electronic annotation
202132_at	WWTR1	AA081084	2.05	WW domain containing transcription regulator 1	chr3q23-q24	chr3:150717711-150903750 (-)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; non-traceable author statement ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation	3713 ; transcription coactivator activity ; non-traceable author statement
206214_at	PLA2G7	NM_005084	2.05	phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) ; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)	chr6p21.2-p12	chr6:46780237-46811002 (-)	6954 ; inflammatory response ; traceable author statement ; 16042 ; lipid catabolism ; inferred from electronic annotation ; 6629 ; lipid metabolism ; traceable author statement	3847 ; 1-alkyl-2-acetylglycerophosphocholine esterase activity ; inferred from electronic annotation ; 5543 ; phospholipid binding ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation
202206_at	ARL7	AW450363	2.05	ADP-ribosylation factor-like 7	chr2q37.1	chr2:235066420-235070361 (-)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
242471_at		AI916641	2.05	Transcribed locus	chr1q21.1	chr1:142649919-142650430 (+)
212599_at	AUTS2	AK025298	2.05	autism susceptibility candidate 2	chr7q11.22	chr7:68702835-69895990 (+)
219489_s_at	RHBDL2	NM_017821	2.04	nucleoredoxin	chr17p13.3	chr1:39124554-39157442 (-)	6118 ; electron transport ; inferred from electronic annotation	5489 ; electron transporter activity ; inferred from electronic annotation ; 9055 ; electron carrier activity ; inferred from electronic annotation
225442_at	DDR2	AI799915	2.04	Discoidin domain receptor family, member 2	chr1	chr1:161021184-161023163 (+)	6468 ; protein amino acid phosphorylation ; inferred from electronic annotation ; 7155 ; cell adhesion ; inferred from electronic annotation ; 7155 ; cell adhesion ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7169 ; transmembrane receptor protein tyrosine kinase signaling pathway ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; inferred from electronic annotation ; 4714 ; transmembrane receptor protein tyrosine kinase activity ; traceable author statement ; 4872 ; receptor activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
225265_at	RBMS1	AI580100	2.04	RNA binding motif, single stranded interacting protein 1	chr2q24.2	chr2:160836907-160839258 (-)	6260 ; DNA replication ; traceable author statement ; 6396 ; RNA processing ; traceable author statement ; 6445 ; regulation of translation ; traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation ; 6260 ; DNA replication ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 3690 ; double-stranded DNA binding ; traceable author statement ; 3697 ; single-stranded DNA binding ; traceable author statement ; 3723 ; RNA binding ; non-traceable author statement ; 3676 ; nucleic acid binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3723 ; RNA binding ; inferred from electronic annotation ; 3690 ; double-stranded DNA binding ; non-traceable author statement ; 3697 ; single-stranded DNA binding ; non-traceable author statement
201615_x_at	CALD1	AI685060	2.03	caldesmon 1	chr7q33	chr7:134114915-134305231 (+)	6936 ; muscle contraction ; inferred from electronic annotation ; 7517 ; muscle development ; inferred from electronic annotation	3779 ; actin binding ; traceable author statement ; 5516 ; calmodulin binding ; traceable author statement ; 5523 ; tropomyosin binding ; traceable author statement ; 17022 ; myosin binding ; inferred from electronic annotation ; 3779 ; actin binding ; inferred from electronic annotation ; 5516 ; calmodulin binding ; inferred from electronic annotation
202207_at	ARL7	BG435404	2.03	ADP-ribosylation factor-like 7	chr2q37.1	chr2:235066420-235070361 (-)	6886 ; intracellular protein transport ; inferred from electronic annotation ; 7264 ; small GTPase mediated signal transduction ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 3924 ; GTPase activity ; traceable author statement ; 5525 ; GTP binding ; inferred from electronic annotation
242181_at		AI521765	2.03	CDNA FLJ33489 fis, clone BRAMY2003585	---	---
232573_at	FBXO32	AL389956	2.02	F-box protein 32	chr8q24.13	chr8:124605135-124606889 (-)	6512 ; ubiquitin cycle ; inferred from electronic annotation
227210_at	SFMBT2	T65020	2.01	Scm-like with four mbt domains 2	chr10	chr10:7240592-7242111 (-)	45449 ; regulation of transcription ; inferred from electronic annotation
233768_at	APG5L	AK022136	2.01	ATG5 autophagy related 5 homolog (S. cerevisiae)	chr6q21	chr6:106878085-106879349 (-)	6914 ; autophagy ; inferred from electronic annotation ; 6915 ; apoptosis ; traceable author statement ; 6915 ; apoptosis ; inferred from electronic annotation
203324_s_at	CAV2	NM_001233	2.00	caveolin 2	chr7q31.1	chr7:115927051-115934224 (+)		5515 ; protein binding ; inferred from physical interaction ; 42803 ; protein homodimerization activity ; inferred from direct assay
212944_at	MRPS6	AK024896	2.00	Mitochondrial ribosomal protein S6	chr21q21.3-q22.1	chr21:34398194-34400429 (+)	6412 ; protein biosynthesis ; non-traceable author statement ; 6412 ; protein biosynthesis ; inferred from electronic annotation	3735 ; structural constituent of ribosome ; non-traceable author statement ; 3735 ; structural constituent of ribosome ; inferred from electronic annotation
204446_s_at	ALOX5	NM_000698	2.00	arachidonate 5-lipoxygenase	chr10q11.2	chr10:45189691-45261567 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6954 ; inflammatory response ; not recorded ; 19370 ; leukotriene biosynthesis ; inferred from electronic annotation ; 6691 ; leukotriene metabolism ; inferred from electronic annotation ; 6691 ; leukotriene metabolism ; traceable author statement	4051 ; arachidonate 5-lipoxygenase activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 16165 ; lipoxygenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4051 ; arachidonate 5-lipoxygenase activity ; inferred from electronic annotation ; 16702 ; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
218692_at	FLJ20366	NM_017786	0.50	hypothetical protein FLJ20366	chr8q23.2	chr8:110655590-110773009 (-)
207655_s_at	BLNK	NM_013314	0.50	B-cell linker	chr10q23.2-q23.33	chr10:97941452-98021287 (-)	7242 ; intracellular signaling cascade ; inferred from electronic annotation ; 42113 ; B cell activation ; inferred from electronic annotation
218756_s_at	MGC4172	NM_024308	0.50	short-chain dehydrogenase/reductase	chr17q12	chr17:32022452-32031344 (+)	8152 ; metabolism ; inferred from electronic annotation	16491 ; oxidoreductase activity ; inferred from electronic annotation
238935_at	RPS27L	AW958475	0.50	Ribosomal protein S27-like	chr15q22.2	chr15:61232593-61233030 (-)	6412 ; protein biosynthesis ; inferred from electronic annotation	3735 ; structural constituent of ribosome ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
202712_s_at	CKMT1; UMTCK	NM_020990	0.50	creatine kinase, mitochondrial 1B ; creatine kinase, mitochondrial 1A	chr15q15	chr15:41673545-41678874 (+)		4111 ; creatine kinase activity ; traceable author statement ; 4111 ; creatine kinase activity ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16772 ; transferase activity, transferring phosphorus-containing groups ; inferred from electronic annotation
225488_at	DERL1	AI967978	0.50	Der1-like domain family, member 1	chr8q24.13	chr8:124095568-124123733 (-)	15031 ; protein transport ; inferred from electronic annotation ; 19060 ; intracellular viral protein transport ; traceable author statement ; 30433 ; ER-associated protein catabolism ; inferred from direct assay ; 30968 ; unfolded protein response ; inferred from direct assay ; 30970 ; retrograde protein transport, ER to cytosol ; inferred from direct assay ; 6810 ; transport ; inferred from electronic annotation ; 45184 ; establishment of protein localization ; traceable author statement	4872 ; receptor activity ; non-traceable author statement ; 5515 ; protein binding ; inferred from physical interaction
243588_at	FARP1	N74058	0.50	FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)	chr13q32.2	chr13:97716559-97716913 (+)	7155 ; cell adhesion ; inferred from electronic annotation	5085 ; guanyl-nucleotide exchange factor activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from electronic annotation ; 8092 ; cytoskeletal protein binding ; inferred from electronic annotation ; 5089 ; Rho guanyl-nucleotide exchange factor activity ; traceable author statement
236001_at	LOC400573	BF446940	0.49	hypothetical gene supported by BC015790; BC041634	chr17p13.1	chr17:10638954-10647986 (-)
224272_at	FKSG42	AF334184	0.49	FKSG42	chr12q12	chr12:43742667-43745461 (-)
218493_at	C16orf33	NM_024571	0.49	chromosome 16 open reading frame 33	chr16p13.3	chr16:43009-47443 (+)	398 ; nuclear mRNA splicing, via spliceosome ; inferred from electronic annotation ; 6397 ; mRNA processing ; inferred from electronic annotation ; 6464 ; protein modification ; inferred from electronic annotation
221122_at	HRASLS2	NM_017878	0.49	HRAS-like suppressor 2	chr11q12.3	chr11:63076817-63087431 (-)
215299_x_at	SULT1A1; PST; STP; STP1; P-PST; ST1A3; TSPST1; MGC5163; HAST1/HAST2	U37025	0.49	sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1	chr16p12.1	chr16:28524331-28525431 (-)	6584 ; catecholamine metabolism ; inferred from electronic annotation ; 6629 ; lipid metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 9308 ; amine metabolism ; traceable author statement ; 9309 ; amine biosynthesis ; traceable author statement ; 7268 ; synaptic transmission ; not recorded ; 6281 ; DNA repair ; inferred from electronic annotation	4062 ; aryl sulfotransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; traceable author statement ; 4062 ; aryl sulfotransferase activity ; traceable author statement ; 4518 ; nuclease activity ; inferred from electronic annotation
202587_s_at	AK1	BC001116	0.49	adenylate kinase 1	chr9q34.1	chr9:129669941-129679763 (-)	6139 ; nucleobase, nucleoside, nucleotide and nucleic acid metabolism ; inferred from electronic annotation ; 46034 ; ATP metabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4017 ; adenylate kinase activity ; inferred from electronic annotation ; 4017 ; adenylate kinase activity ; traceable author statement ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 19201 ; nucleotide kinase activity ; inferred from electronic annotation
202201_at	BLVRB	NM_000713	0.49	biliverdin reductase B (flavin reductase (NADPH))	chr19q13.1-q13.2	chr19:45645540-45663517 (-)	9225 ; nucleotide-sugar metabolism ; inferred from electronic annotation	4074 ; biliverdin reductase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 42602 ; flavin reductase activity ; inferred from electronic annotation ; 51287 ; NAD binding ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4074 ; biliverdin reductase activity ; inferred from electronic annotation
236655_at	TPD52	AI632972	0.48	tumor protein D52	chr8q21	chr8:81109661-81110209 (-)	9653 ; morphogenesis ; traceable author statement
213421_x_at	PRSS3	AW007273	0.48	protease, serine, 3 (mesotrypsin)	chr9p11.2	chr9:33740642-33789228 (+)	6508 ; proteolysis ; non-traceable author statement ; 7586 ; digestion ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; inferred from electronic annotation ; 6508 ; proteolysis ; traceable author statement	4295 ; trypsin activity ; non-traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 4295 ; trypsin activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
231230_at		AI693366	0.48	Transcribed locus	chr14	chr14:87719510-87719992 (-)
220133_at	APIN	NM_017855	0.48	APin protein	chr4q13.3	chr4:71098420-71104750 (+)
209667_at		BF033242	0.48	carboxylesterase 2 (intestine, liver)	chr16q22.1	chr16:65526848-65536500 (+)	9056 ; catabolism ; traceable author statement	4759 ; serine esterase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4091 ; carboxylesterase activity ; inferred from electronic annotation ; 4091 ; carboxylesterase activity ; traceable author statement
210378_s_at	SSNA1	BC004118	0.48	Sjogrens syndrome nuclear autoantigen 1	chr9q34.3	chr9:139202932-139204643 (+)
203021_at	SLPI	NM_003064	0.48	secretory leukocyte peptidase inhibitor	chr20q12	chr20:43314292-43316616 (-)		4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4866 ; endopeptidase inhibitor activity ; traceable author statement
234297_at	RGS8	AL359941	0.48	Regulator of G-protein signalling 8 ; MRNA; cDNA DKFZp547D135 (from clone DKFZp547D135)	chr1q25	---	9968 ; negative regulation of signal transduction ; inferred from electronic annotation	4871 ; signal transducer activity ; inferred from electronic annotation
211689_s_at	TMPRSS2	AF270487	0.48	transmembrane protease, serine 2 ; transmembrane protease, serine 2	chr21q22.3	chr21:41759805-41791988 (-)	6508 ; proteolysis ; inferred from electronic annotation	4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 5044 ; scavenger receptor activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 8236 ; serine-type peptidase activity ; traceable author statement
216594_x_at	AKR1C1	S68290	0.48	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	chr10p15-p14	chr10:4995645-5010038 (+)	6805 ; xenobiotic metabolism ; traceable author statement ; 6629 ; lipid metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 6629 ; lipid metabolism ; traceable author statement ; 6810 ; transport ; traceable author statement ; 7586 ; digestion ; traceable author statement ; 15721 ; bile acid transport ; traceable author statement ; 15722 ; canalicular bile acid transport ; traceable author statement	4033 ; aldo-keto reductase activity ; traceable author statement ; 5488 ; binding ; traceable author statement ; 5489 ; electron transporter activity ; not recorded ; 15125 ; bile acid transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 47006 ; 20-alpha-hydroxysteroid dehydrogenase activity ; inferred from electronic annotation ; 47115 ; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity ; inferred from electronic annotation ; 47026 ; 3-alpha-hydroxysteroid dehydrogenase (A-specific) activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement
227676_at	FAM3D	AW001287	0.48	family with sequence similarity 3, member D	chr3p14.2	chr3:58594709-58597187 (-)	46676 ; negative regulation of insulin secretion ; inferred from direct assay	5125 ; cytokine activity ; non-traceable author statement
208473_s_at	GP2	NM_016295	0.47	glycoprotein 2 (zymogen granule membrane)	chr16p12	chr16:20230045-20245233 (-)
214440_at	NAT1	NM_000662	0.47	N-acetyltransferase 1 (arylamine N-acetyltransferase)	chr8p23.1-p21.3	chr8:18123690-18125100 (+)	8152 ; metabolism ; inferred from electronic annotation	4060 ; arylamine N-acetyltransferase activity ; inferred from electronic annotation ; 4060 ; arylamine N-acetyltransferase activity ; traceable author statement ; 16407 ; acetyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 8415 ; acyltransferase activity ; inferred from electronic annotation
229158_at	WNK4	AW082836	0.47	WNK lysine deficient protein kinase 4	chr17q21-q22	chr17:38202127-38202608 (+)	6468 ; protein amino acid phosphorylation ; inferred from sequence or structural similarity ; 6811 ; ion transport ; inferred from sequence or structural similarity ; 7243 ; protein kinase cascade ; inferred from sequence or structural similarity ; 50794 ; regulation of cellular process ; inferred from sequence or structural similarity ; 6468 ; protein amino acid phosphorylation ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from sequence or structural similarity ; 4713 ; protein-tyrosine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from sequence or structural similarity ; 16740 ; transferase activity ; inferred from electronic annotation ; 4672 ; protein kinase activity ; inferred from electronic annotation ; 4674 ; protein serine/threonine kinase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16301 ; kinase activity ; inferred from electronic annotation
219580_s_at	TMC5	NM_024780	0.47	transmembrane channel-like 5	chr16p12.3	chr16:19393007-19417579 (+)
204034_at	ETHE1	NM_014297	0.47	ethylmalonic encephalopathy 1	chr19q13.31	chr19:48702711-48722992 (-)		16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
228398_at	SENP8	AW173305	0.47	SUMO/sentrin specific peptidase family member 8	chr15q23	chr15:70197718-70220358 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 6512 ; ubiquitin cycle ; inferred from electronic annotation	8234 ; cysteine-type peptidase activity ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
227850_x_at	CDC42EP5	AW084544	0.47	CDC42 effector protein (Rho GTPase binding) 5	chr19q13.42	chr19:59668021-59668479 (-)	8360 ; regulation of cell shape ; inferred from direct assay ; 30838 ; positive regulation of actin filament polymerization ; inferred from direct assay ; 31274 ; positive regulation of pseudopodium formation ; inferred from direct assay ; 8360 ; regulation of cell shape ; inferred from electronic annotation	17049 ; GTP-Rho binding ; inferred from physical interaction
228051_at	LOC202451	AI979261	0.47	hypothetical protein LOC202451	chr6q23.3	chr6:138706308-138707493 (+)
222520_s_at	ESRRBL1	AF139576	0.47	estrogen-related receptor beta like 1	chr3q13.12	chr3:109362349-109423938 (-)	6915 ; apoptosis ; inferred from direct assay ; 6919 ; caspase activation ; inferred from direct assay ; 42981 ; regulation of apoptosis ; inferred from direct assay	5515 ; protein binding ; inferred from direct assay ; 4872 ; receptor activity ; inferred from electronic annotation
229499_at	CAPN13	AI762355	0.46	calpain 13	chr2	chr2:30799140-30819888 (-)	6508 ; proteolysis ; inferred from electronic annotation	4198 ; calpain activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation
231270_at	CA13	BF111998	0.46	carbonic anhydrase XIII	chr8q21.2	chr8:86382978-86383551 (+)	6730 ; one-carbon compound metabolism ; inferred from electronic annotation	4089 ; carbonate dehydratase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
208813_at	GOT1	BC000498	0.46	glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)	chr10q24.1-q25.1	chr10:101147031-101180340 (-)	6520 ; amino acid metabolism ; inferred from electronic annotation ; 6533 ; aspartate catabolism ; traceable author statement ; 9058 ; biosynthesis ; inferred from electronic annotation	4069 ; aspartate transaminase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 8483 ; transaminase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16769 ; transferase activity, transferring nitrogenous groups ; inferred from electronic annotation
235145_at	ZFP67	BE778059	0.46	Zinc finger and BTB domain containing 7B	chr1q21.3	chr1:153256414-153257623 (+)	6350 ; transcription ; inferred from electronic annotation ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7398 ; ectoderm development ; traceable author statement ; 30154 ; cell differentiation ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 3704 ; specific RNA polymerase II transcription factor activity ; traceable author statement ; 5515 ; protein binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3676 ; nucleic acid binding ; inferred from electronic annotation
226611_s_at	PRR6	AA722878	0.46	proline rich 6	chr17p11.2	chr17:16186568-16197449 (-)	8152 ; metabolism ; inferred from electronic annotation	16846 ; carbon-sulfur lyase activity ; inferred from electronic annotation
207463_x_at	PRSS3	NM_002771	0.46	protease, serine, 3 (mesotrypsin)	chr9p11.2	chr7:142158403-142182361 (+)	6508 ; proteolysis ; non-traceable author statement ; 7586 ; digestion ; traceable author statement ; 6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; inferred from electronic annotation ; 6508 ; proteolysis ; traceable author statement	4295 ; trypsin activity ; non-traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 4295 ; trypsin activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
216806_at		AL136306	0.46		chr6	chr6:54597361-54598245 (+)
204151_x_at	AKR1C1	NM_001353	0.46	aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase)	chr10p15-p14	chr10:4995631-5010157 (+)	6805 ; xenobiotic metabolism ; traceable author statement ; 6629 ; lipid metabolism ; inferred from electronic annotation ; 8202 ; steroid metabolism ; inferred from electronic annotation ; 6629 ; lipid metabolism ; traceable author statement ; 6810 ; transport ; traceable author statement ; 7586 ; digestion ; traceable author statement ; 15721 ; bile acid transport ; traceable author statement ; 15722 ; canalicular bile acid transport ; traceable author statement	4033 ; aldo-keto reductase activity ; traceable author statement ; 5488 ; binding ; traceable author statement ; 5489 ; electron transporter activity ; not recorded ; 15125 ; bile acid transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 47006 ; 20-alpha-hydroxysteroid dehydrogenase activity ; inferred from electronic annotation ; 47115 ; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity ; inferred from electronic annotation ; 47026 ; 3-alpha-hydroxysteroid dehydrogenase (A-specific) activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement
204623_at	TFF3	NM_003226	0.45	trefoil factor 3 (intestinal)	chr21q22.3	chr21:42605252-42608532 (-)	6952 ; defense response ; traceable author statement ; 7586 ; digestion ; traceable author statement
229835_s_at	C20orf45	AA004210	0.45	Chromosome 20 open reading frame 45	chr20	chr20:57042715-57043369 (+)
227196_at	RHPN2	BG054987	0.45	rhophilin, Rho GTPase binding protein 2	chr19q13.11	chr16:33312159-33333380 (+)	7165 ; signal transduction ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation
227981_at	CYB561D1	AI741458	0.45	cytochrome b-561 domain containing 1	chr1	chr1:109838235-109844586 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation	5506 ; iron ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
219508_at	GCNT3	NM_004751	0.45	glucosaminyl (N-acetyl) transferase 3, mucin type	chr15q21.3	chr15:57696079-57699494 (+)	6493 ; protein amino acid O-linked glycosylation ; traceable author statement ; 5975 ; carbohydrate metabolism ; non-traceable author statement	8375 ; acetylglucosaminyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 8109 ; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity ; traceable author statement
239370_at		AW081982	0.45		chr1	chr1:158213360-158215473 (+)
223895_s_at	EPN3	BC001038	0.45	epsin 3	chr17q21.33	chr17:45965117-45974724 (+)		8289 ; lipid binding ; inferred from electronic annotation
225795_at	LOC91689	AV751709	0.45	hypothetical gene supported by AL449243	chr22q13.2	chr22:40805651-40809303 (+)
201691_s_at	TPD52	NM_005079	0.44	tumor protein D52	chr8q21	chr8:81110303-81246324 (-)	9653 ; morphogenesis ; traceable author statement
231297_at	DOT1L	AI479899	0.44	DOT1-like, histone H3 methyltransferase (S. cerevisiae)	chr19p13.3	chr19:2179172-2181014 (+)	16568 ; chromatin modification ; inferred from electronic annotation	8168 ; methyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 18024 ; histone-lysine N-methyltransferase activity ; inferred from electronic annotation
205929_at	GPA33	NM_005814	0.44	glycoprotein A33 (transmembrane)	chr1q24.1	chr1:165288705-165326492 (-)		4872 ; receptor activity ; traceable author statement
214070_s_at	ATP10B	AW006935	0.44	ATPase, Class V, type 10B	chr5q34	chr5:159922716-159982151 (-)	6812 ; cation transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 287 ; magnesium ion binding ; inferred from electronic annotation ; 4012 ; phospholipid-translocating ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from electronic annotation ; 15662 ; ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
213296_at	PEX10	BF339133	0.44	Peroxisome biogenesis factor 10	chr1	chr1:2326059-2326735 (+)	7031 ; peroxisome organization and biogenesis ; inferred from direct assay ; 16558 ; protein import into peroxisome matrix ; inferred from direct assay ; 16567 ; protein ubiquitination ; inferred from electronic annotation	4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 5515 ; protein binding ; inferred from physical interaction ; 8270 ; zinc ion binding ; non-traceable author statement ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
236979_at	FLJ22588	AI821801	0.44	chromosome 1 open reading frame 178	chr1p13.2	chr1:114225148-114231692 (-)
64408_s_at	CALML4	AW025529	0.43	calmodulin-like 4	chr15q23	chr15:66273193-66279070 (-)		5509 ; calcium ion binding ; inferred from electronic annotation
229283_at	PDCD6	AA960804	0.43	programmed cell death 6	chr5pter-p15.2	chr5:268343-269166 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 8624 ; induction of apoptosis by extracellular signals ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 30528 ; transcription regulator activity ; inferred from electronic annotation
226597_at	C19orf32	AI348159	0.43	chromosome 19 open reading frame 32	chr19p13.3	chr19:1442076-1448926 (+)		4872 ; receptor activity ; inferred from electronic annotation
204351_at	S100P	NM_005980	0.43	S100 calcium binding protein P	chr4p16	chr4:6746539-6749792 (+)		287 ; magnesium ion binding ; traceable author statement ; 5509 ; calcium ion binding ; traceable author statement ; 48306 ; calcium-dependent protein binding ; inferred from physical interaction ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 5515 ; protein binding ; traceable author statement
204167_at	BTD	NM_000060	0.43	biotinidase	chr3p25	chr3:15618326-15662328 (+)	6768 ; biotin metabolism ; not recorded ; 6807 ; nitrogen compound metabolism ; inferred from electronic annotation ; 7417 ; central nervous system development ; traceable author statement ; 8544 ; epidermis development ; traceable author statement	4075 ; biotin carboxylase activity ; traceable author statement ; 47708 ; biotinidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 16810 ; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds ; inferred from electronic annotation ; 16811 ; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides ; inferred from electronic annotation
214307_at	HGD	AI478172	0.43	homogentisate 1,2-dioxygenase (homogentisate oxidase)	chr3	chr3_random:59672-68135 (+)	6559 ; L-phenylalanine catabolism ; inferred from electronic annotation ; 6559 ; L-phenylalanine catabolism ; traceable author statement ; 6570 ; tyrosine metabolism ; inferred from electronic annotation ; 6572 ; tyrosine catabolism ; traceable author statement ; 6572 ; tyrosine catabolism ; inferred from electronic annotation	4411 ; homogentisate 1,2-dioxygenase activity ; inferred from electronic annotation ; 4411 ; homogentisate 1,2-dioxygenase activity ; traceable author statement ; 5506 ; iron ion binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 16702 ; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen ; inferred from electronic annotation
205623_at	ALDH3A1	NM_000691	0.43	aldehyde dehydrogenase 3 family, memberA1	chr17p11.2	chr17:19581892-19592200 (-)	5975 ; carbohydrate metabolism ; traceable author statement ; 6081 ; aldehyde metabolism ; traceable author statement ; 8152 ; metabolism ; inferred from electronic annotation	4030 ; aldehyde dehydrogenase [NAD(P)+] activity ; inferred from electronic annotation ; 5489 ; electron transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4028 ; aldehyde dehydrogenase activity ; traceable author statement
201119_s_at	COX8A	NM_004074	0.43	cytochrome c oxidase subunit 8A (ubiquitous)	chr11q12-q13	chr11:63498687-63500590 (+)	6118 ; electron transport ; inferred from electronic annotation ; 6091 ; generation of precursor metabolites and energy ; traceable author statement	4129 ; cytochrome-c oxidase activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 4129 ; cytochrome-c oxidase activity ; inferred from electronic annotation
239761_at	GCNT1	AI088120	0.43	glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase)	chr9q13	chr9:78309797-78310519 (+)	6493 ; protein amino acid O-linked glycosylation ; traceable author statement	3829 ; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity ; traceable author statement ; 16757 ; transferase activity, transferring glycosyl groups ; inferred from electronic annotation ; 3829 ; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity ; inferred from electronic annotation ; 8375 ; acetylglucosaminyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
209735_at	ABCG2	AF098951	0.43	ATP-binding cassette, sub-family G (WHITE), member 2	chr4q22	chr4:89232224-89298777 (-)	6810 ; transport ; traceable author statement ; 42493 ; response to drug ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 5215 ; transporter activity ; traceable author statement ; 5524 ; ATP binding ; traceable author statement ; 8559 ; xenobiotic-transporting ATPase activity ; traceable author statement ; 16887 ; ATPase activity ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation ; 42626 ; ATPase activity, coupled to transmembrane movement of substances ; inferred from electronic annotation ; 42626 ; ATPase activity, coupled to transmembrane movement of substances ; traceable author statement
204272_at	LGALS4	NM_006149	0.42	lectin, galactoside-binding, soluble, 4 (galectin 4)	chr19q13.2	chr19:43984154-43995422 (-)	7155 ; cell adhesion ; traceable author statement	5529 ; sugar binding ; traceable author statement ; 5529 ; sugar binding ; inferred from electronic annotation
205632_s_at	PIP5K1B	NM_003558	0.42	phosphatidylinositol-4-phosphate 5-kinase, type I, beta	chr9q13	chr9:70510435-70813911 (+)		16301 ; kinase activity ; inferred from electronic annotation ; 16308 ; 1-phosphatidylinositol-4-phosphate 5-kinase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation
209869_at	ADRA2A	AF284095	0.42	adrenergic, alpha-2A-, receptor ; adrenergic, alpha-2A-, receptor	chr10q24-q26	chr10:112826910-112830560 (+)	187 ; activation of MAPK activity ; traceable author statement ; 6928 ; cell motility ; traceable author statement ; 7165 ; signal transduction ; traceable author statement ; 7186 ; G-protein coupled receptor protein signaling pathway ; traceable author statement ; 7194 ; negative regulation of adenylate cyclase activity ; traceable author statement ; 7265 ; Ras protein signal transduction ; traceable author statement ; 7266 ; Rho protein signal transduction ; traceable author statement ; 8284 ; positive regulation of cell proliferation ; traceable author statement ; 30036 ; actin cytoskeleton organization and biogenesis ; traceable author statement ; 7165 ; signal transduction ; inferred from electronic annotation ; 7186 ; G-protein coupled receptor protein signaling pathway ; inferred from electronic annotation	1584 ; rhodopsin-like receptor activity ; inferred from electronic annotation ; 4872 ; receptor activity ; inferred from electronic annotation ; 4935 ; adrenoceptor activity ; inferred from electronic annotation ; 4938 ; alpha2-adrenergic receptor activity ; traceable author statement ; 15459 ; potassium channel regulator activity ; traceable author statement ; 4871 ; signal transducer activity ; inferred from electronic annotation ; 4930 ; G-protein coupled receptor activity ; inferred from electronic annotation ; 4938 ; alpha2-adrenergic receptor activity ; inferred from electronic annotation
207847_s_at	MUC1	NM_002456	0.41	mucin 1, transmembrane	chr1q21	chr1:153425164-153429304 (-)		3779 ; actin binding ; inferred from electronic annotation
235117_at	ASB3	AI191897	0.41	similar to RIKEN cDNA 2510006C20 gene	chr2p16	chr2:53848448-53855830 (+)
223312_at	C2orf7	BC005069	0.41	chromosome 2 open reading frame 7	chr2p13.2	chr2:73308643-73313864 (-)	6508 ; proteolysis ; inferred from electronic annotation	8233 ; peptidase activity ; inferred from electronic annotation
224707_at	ORF1-FL49	AL522667	0.41	putative nuclear protein ORF1-FL49	chr5q31.3	chr5:139534913-139603556 (+)
228726_at	SERPINB1	AW512196	0.41	Serpin peptidase inhibitor, clade B (ovalbumin), member 1	chr6	chr6:2777565-2777964 (-)		4867 ; serine-type endopeptidase inhibitor activity ; non-traceable author statement ; 4866 ; endopeptidase inhibitor activity ; inferred from electronic annotation ; 4867 ; serine-type endopeptidase inhibitor activity ; inferred from electronic annotation
229369_at	VSIG2	AI201858	0.41	V-set and immunoglobulin domain containing 2	chr11q24	chr11:124123215-124127299 (-)
217771_at	GOLPH2	NM_016548	0.41	golgi phosphoprotein 2	chr9q21.33	chr9:87830881-87904271 (-)
229964_at	C9orf152	AI380443	0.41	chromosome 9 open reading frame 152	chr9q31.3	chr9:112001668-112002209 (-)
202489_s_at	FXYD3	BC005238	0.41	FXYD domain containing ion transport regulator 3	chr19q13.11-q13.12	chr19:40299061-40306395 (+)	6811 ; ion transport ; inferred from electronic annotation ; 6821 ; chloride transport ; traceable author statement ; 6810 ; transport ; inferred from electronic annotation	5216 ; ion channel activity ; inferred from electronic annotation ; 5254 ; chloride channel activity ; traceable author statement
205517_at	GATA4	AV700724	0.40	GATA binding protein 4	chr8p23.1-p22	chr8:11602946-11654918 (+)	6350 ; transcription ; inferred from electronic annotation ; 6366 ; transcription from RNA polymerase II promoter ; not recorded ; 7275 ; development ; traceable author statement ; 7507 ; heart development ; inferred from mutant phenotype ; 45893 ; positive regulation of transcription, DNA-dependent ; inferred from sequence or structural similarity ; 6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 45941 ; positive regulation of transcription ; inferred from electronic annotation ; 6350 ; transcription ; non-traceable author statement	3700 ; transcription factor activity ; inferred from electronic annotation ; 3702 ; RNA polymerase II transcription factor activity ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16563 ; transcriptional activator activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation ; 3677 ; DNA binding ; not recorded ; 3700 ; transcription factor activity ; non-traceable author statement
237919_at	RFFL	AV660759	0.40	Ring finger and FYVE-like domain containing 1	chr17q12	chr17:30361407-30361812 (+)	6915 ; apoptosis ; inferred from electronic annotation ; 16567 ; protein ubiquitination ; inferred from electronic annotation ; 6512 ; ubiquitin cycle ; inferred from electronic annotation	3677 ; DNA binding ; inferred from electronic annotation ; 4842 ; ubiquitin-protein ligase activity ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
204698_at	ISG20	NM_002201	0.40	interferon stimulated exonuclease gene 20kDa	chr15q26	chr15:86983586-86999884 (+)	738 ; DNA catabolism, exonucleolytic ; inferred from direct assay ; 6401 ; RNA catabolism ; inferred from direct assay ; 8283 ; cell proliferation ; traceable author statement ; 9615 ; response to virus ; inferred from direct assay	175 ; 3-5-exoribonuclease activity ; inferred from direct assay ; 3723 ; RNA binding ; inferred from electronic annotation ; 4527 ; exonuclease activity ; inferred from electronic annotation ; 8310 ; single-stranded DNA specific 3-5 exodeoxyribonuclease activity ; inferred from direct assay ; 8859 ; exoribonuclease II activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 30145 ; manganese ion binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4518 ; nuclease activity ; inferred from electronic annotation
211745_x_at	HBA2	BC005931	0.39	hemoglobin, alpha 1 ; hemoglobin, alpha 1 ; hemoglobin, alpha 2 ; hemoglobin, alpha 2	chr16p13.3	chr16:166678-167521 (+)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation	5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
236543_at		AW301241	0.39	Transcribed locus	chr4q22.1	chr4:92079566-92079980 (+)
231592_at	XIST	AV646335	0.39	X (inactive)-specific transcript	chrXq13.2	chrX:72959000-72959896 (+)
219233_s_at	GSDML	NM_018530	0.39	gasdermin-like	chr17q12	chr17:35314375-35327319 (-)
238385_at	LOC389429	BF825703	0.38	Hypothetical LOC389429	chr6q22.33	chr6:127943101-127954650 (-)
234993_at	C13orf6	BE301702	0.38	chromosome 13 open reading frame 6	chr13q33.3	chr13:107679547-107682337 (+)	6629 ; lipid metabolism ; inferred from electronic annotation ; 6631 ; fatty acid metabolism ; inferred from electronic annotation ; 6725 ; aromatic compound metabolism ; inferred from electronic annotation	3824 ; catalytic activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
224932_at	C22orf16	AI814909	0.38	chromosome 22 open reading frame 16	chr22q11.23	chr22:22438020-22440151 (-)
218211_s_at	MLPH	NM_024101	0.37	melanophilin	chr2q37.3	chr2:238060668-238127375 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation ; 17137 ; Rab GTPase binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
204818_at	HSD17B2	NM_002153	0.37	hydroxysteroid (17-beta) dehydrogenase 2	chr16q24.1-q24.2	chr16:80626363-80689638 (+)	6703 ; estrogen biosynthesis ; not recorded ; 8152 ; metabolism ; inferred from electronic annotation ; 6694 ; steroid biosynthesis ; inferred from electronic annotation ; 8610 ; lipid biosynthesis ; inferred from electronic annotation	4303 ; estradiol 17-beta-dehydrogenase activity ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation
204018_x_at	HBA1	NM_000558	0.37	hemoglobin, alpha 1 ; hemoglobin, alpha 1 ; hemoglobin, alpha 2 ; hemoglobin, alpha 2	chr16p13.3	chr16:166678-167520 (+)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation	5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
209160_at	AKR1C3	AB018580	0.37	aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)	chr10p15-p14	chr10:5126597-5139878 (+)	6629 ; lipid metabolism ; traceable author statement ; 6693 ; prostaglandin metabolism ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	4033 ; aldo-keto reductase activity ; traceable author statement ; 4303 ; estradiol 17-beta-dehydrogenase activity ; inferred from electronic annotation ; 5489 ; electron transporter activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 47026 ; 3-alpha-hydroxysteroid dehydrogenase (A-specific) activity ; inferred from electronic annotation ; 47115 ; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity ; inferred from electronic annotation
223479_s_at	CHCHD5	BC004498	0.37	coiled-coil-helix-coiled-coil-helix domain containing 5	chr2q13	chr2:113058506-113063088 (+)
237212_at		BF195312	0.36	Transcribed locus	chr2q14.2	chr2:119740771-119741245 (+)
230570_at		AI702465	0.36	Transcribed locus	chr8	chr8:117723552-117724010 (-)
206681_x_at	GP2	NM_001502	0.36	glycoprotein 2 (zymogen granule membrane)	chr16p12	chr16:20229594-20245292 (-)
203908_at	SLC4A4	NM_003759	0.36	solute carrier family 4, sodium bicarbonate cotransporter, member 4	chr4q21	chr4:72423680-72656663 (+)	6820 ; anion transport ; inferred from electronic annotation ; 6810 ; transport ; traceable author statement	5452 ; inorganic anion exchanger activity ; inferred from electronic annotation ; 15380 ; anion exchanger activity ; inferred from electronic annotation ; 8510 ; sodium:bicarbonate symporter activity ; traceable author statement
224355_s_at	MS4A8B	AF237905	0.36	membrane-spanning 4-domains, subfamily A, member 8B ; membrane-spanning 4-domains, subfamily A, member 8B	chr11q12.2	chr11:60223622-60239858 (+)	7165 ; signal transduction ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation
206797_at	NAT2	NM_000015	0.36	N-acetyltransferase 2 (arylamine N-acetyltransferase)	chr8p22	chr8:18293034-18302962 (+)	8152 ; metabolism ; inferred from electronic annotation	4060 ; arylamine N-acetyltransferase activity ; traceable author statement ; 16407 ; acetyltransferase activity ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4060 ; arylamine N-acetyltransferase activity ; inferred from electronic annotation ; 8415 ; acyltransferase activity ; inferred from electronic annotation
224870_at	KIAA0114	BG255416	0.36	KIAA0114 gene product	chr4q12	chr4:53273356-53275061 (+)
205402_x_at	PRSS2	NM_002770	0.35	protease, serine, 2 (trypsin 2)	chr7q34	chr7:142178777-142182363 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; inferred from electronic annotation ; 6508 ; proteolysis ; not recorded	4295 ; trypsin activity ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 4252 ; serine-type endopeptidase activity ; inferred from electronic annotation ; 4295 ; trypsin activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
218679_s_at	VPS28	NM_016208	0.35	vacuolar protein sorting 28 (yeast)	chr8q24.3	chr8:145619807-145623174 (-)	15031 ; protein transport ; inferred from electronic annotation ; 6810 ; transport ; inferred from electronic annotation
219640_at	CLDN15	NM_014343	0.35	claudin 15	chr7q11.22	chr7:100662093-100667836 (-)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
203029_s_at	PTPRN2	NM_002847	0.34	protein tyrosine phosphatase, receptor type, N polypeptide 2	chr7q36	chr7:157024520-158073128 (-)	6470 ; protein amino acid dephosphorylation ; traceable author statement ; 6470 ; protein amino acid dephosphorylation ; inferred from electronic annotation	4872 ; receptor activity ; inferred from electronic annotation ; 5001 ; transmembrane receptor protein tyrosine phosphatase activity ; traceable author statement ; 16787 ; hydrolase activity ; inferred from electronic annotation ; 4721 ; phosphoprotein phosphatase activity ; inferred from electronic annotation ; 4725 ; protein tyrosine phosphatase activity ; inferred from electronic annotation ; 4725 ; protein tyrosine phosphatase activity ; traceable author statement
211696_x_at	HBB	AF349114	0.34	hemoglobin, beta ; hemoglobin, beta	chr11p15.5	chr11:5203301-5204862 (-)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; traceable author statement ; 15671 ; oxygen transport ; non-traceable author statement ; 30185 ; nitric oxide transport ; non-traceable author statement ; 45429 ; positive regulation of nitric oxide biosynthesis ; non-traceable author statement	5515 ; protein binding ; inferred from direct assay ; 8430 ; selenium binding ; inferred from direct assay ; 19825 ; oxygen binding ; inferred from direct assay ; 30492 ; hemoglobin binding ; inferred from direct assay ; 5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5344 ; oxygen transporter activity ; non-traceable author statement
40472_at	LOC254531	AF007155	0.34	PLSC domain containing protein	chr15q14	chr15:32438341-32445196 (-)	8152 ; metabolism ; inferred from electronic annotation	5509 ; calcium ion binding ; inferred from electronic annotation ; 8415 ; acyltransferase activity ; inferred from electronic annotation
209950_s_at	VILL	BC004300	0.33	villin-like	chr3p21.3	chr3:38007291-38023679 (+)	7010 ; cytoskeleton organization and biogenesis ; inferred from electronic annotation ; 51016 ; barbed-end actin filament capping ; inferred from electronic annotation	3779 ; actin binding ; inferred from electronic annotation ; 5200 ; structural constituent of cytoskeleton ; traceable author statement ; 5509 ; calcium ion binding ; inferred from electronic annotation
211699_x_at	HBA1	AF349571	0.32	hemoglobin, alpha 1 ; hemoglobin, alpha 1 ; hemoglobin, alpha 2 ; hemoglobin, alpha 2	chr16p13.3	chr16:166690-167447 (+)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation	5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
238103_at		BF594323	0.32	CDNA clone IMAGE:4806358	chr4	chr4:165894893-165942224 (+)
229150_at	MLPH	AI810764	0.31	Melanophilin	chr2q37.3	chr2:238086003-238086502 (+)	6886 ; intracellular protein transport ; inferred from electronic annotation	5515 ; protein binding ; inferred from electronic annotation ; 17137 ; Rab GTPase binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 8270 ; zinc ion binding ; inferred from electronic annotation
217232_x_at	HBB; hemoglobin	AF059180	0.31	hemoglobin, beta	chr11p15.5	chr11:5203403-5204853 (-)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; traceable author statement ; 15671 ; oxygen transport ; non-traceable author statement ; 30185 ; nitric oxide transport ; non-traceable author statement ; 45429 ; positive regulation of nitric oxide biosynthesis ; non-traceable author statement	5515 ; protein binding ; inferred from direct assay ; 8430 ; selenium binding ; inferred from direct assay ; 19825 ; oxygen binding ; inferred from direct assay ; 30492 ; hemoglobin binding ; inferred from direct assay ; 5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5344 ; oxygen transporter activity ; non-traceable author statement
209301_at	CA2	M36532	0.31	carbonic anhydrase II	chr8q22	chr8:86563521-86580806 (+)	6730 ; one-carbon compound metabolism ; inferred from electronic annotation	4089 ; carbonate dehydratase activity ; traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16829 ; lyase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4089 ; carbonate dehydratase activity ; inferred from electronic annotation
231856_at	KIAA1244	AB033070	0.31	KIAA1244	chr6q23.3	chr6:138624362-138701629 (+)
220383_at	ABCG5	NM_022436	0.30	ATP-binding cassette, sub-family G (WHITE), member 5 (sterolin 1)	chr2p21	chr2:43893480-43919428 (-)	6810 ; transport ; inferred from electronic annotation ; 30299 ; cholesterol absorption ; non-traceable author statement	166 ; nucleotide binding ; inferred from electronic annotation ; 5524 ; ATP binding ; inferred from electronic annotation ; 16887 ; ATPase activity ; inferred from electronic annotation ; 42626 ; ATPase activity, coupled to transmembrane movement of substances ; inferred from electronic annotation ; 17111 ; nucleoside-triphosphatase activity ; inferred from electronic annotation
204875_s_at	GMDS	NM_001500	0.30	GDP-mannose 4,6-dehydratase	chr6p25	chr6:1569077-2190730 (-)	5975 ; carbohydrate metabolism ; traceable author statement ; 7159 ; leukocyte adhesion ; non-traceable author statement ; 9058 ; biosynthesis ; inferred from electronic annotation ; 9225 ; nucleotide-sugar metabolism ; inferred from electronic annotation ; 42351 ; de novo GDP-L-fucose biosynthesis ; traceable author statement	8446 ; GDP-mannose 4,6-dehydratase activity ; inferred from electronic annotation ; 8446 ; GDP-mannose 4,6-dehydratase activity ; traceable author statement ; 16829 ; lyase activity ; inferred from electronic annotation ; 51287 ; NAD binding ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation
202929_s_at	DDT	NM_001355	0.30	D-dopachrome tautomerase	chr22q11.23	chr22:22643561-22652019 (-)	6583 ; melanin biosynthesis from tyrosine ; inferred from electronic annotation	4167 ; dopachrome isomerase activity ; traceable author statement ; 16853 ; isomerase activity ; inferred from electronic annotation
231033_at		AI819863	0.29	Full length insert cDNA clone YI40A07	chr18	chr18:26892809-26893332 (-)
220639_at	FLJ22800	NM_024795	0.29	transmembrane 4 L six family member 20	chr2q36.3	chr2:227935123-227952264 (-)
240200_at	SULT1C1	AI307799	0.28	sulfotransferase family, cytosolic, 1C, member 1	chr2q11.1-q11.2	---	9308 ; amine metabolism ; traceable author statement	8146 ; sulfotransferase activity ; traceable author statement ; 16740 ; transferase activity ; inferred from electronic annotation ; 8146 ; sulfotransferase activity ; inferred from electronic annotation
232322_x_at	STARD10	D60944	0.28	START domain containing 10	chr11q13	chr11:72143422-72143830 (-)
227306_at		AK024898	0.28	CDNA: FLJ21245 fis, clone COL01184	chr9	chr9:19443206-19445169 (+)
228707_at	CLDN23	BF110053	0.28	claudin 23	chr8p23.1	chr8:8598125-8599016 (+)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
214414_x_at	HBA1	T50399	0.27	hemoglobin, alpha 2 ; hemoglobin, alpha 2	chr16p13.3	chr16:163221-163705 (+)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation	5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
220318_at	EPN3	NM_017957	0.26	epsin 3	chr17q21.33	chr17:45965097-45975160 (+)		8289 ; lipid binding ; inferred from electronic annotation
208063_s_at	CAPN9	NM_006615	0.26	calpain 9	chr1q42.11-q42.3	chr1:228949752-229004131 (+)	6508 ; proteolysis ; inferred from electronic annotation ; 7586 ; digestion ; traceable author statement	4198 ; calpain activity ; traceable author statement ; 5509 ; calcium ion binding ; traceable author statement ; 4197 ; cysteine-type endopeptidase activity ; inferred from electronic annotation ; 4198 ; calpain activity ; inferred from electronic annotation ; 5509 ; calcium ion binding ; inferred from electronic annotation ; 8233 ; peptidase activity ; inferred from electronic annotation ; 8234 ; cysteine-type peptidase activity ; inferred from electronic annotation ; 16787 ; hydrolase activity ; inferred from electronic annotation
238984_at	REG4	AI739241	0.26		chr1	chr1:120145315-120145959 (-)
228232_s_at	VSIG2	NM_014312	0.26	V-set and immunoglobulin domain containing 2	chr11q24	chr11:124122577-124127243 (-)
223103_at	STARD10	AF151810	0.25	START domain containing 10	chr11q13	chr11:72143531-72181939 (-)
228706_s_at	CLDN23	BF110053	0.25	claudin 23	chr8p23.1	chr8:8598125-8599016 (+)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
209458_x_at	HBA1	AF105974	0.25	hemoglobin, alpha 1 ; hemoglobin, alpha 1 ; hemoglobin, alpha 2 ; hemoglobin, alpha 2	chr16p13.3	chr16:166694-167448 (+)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation	5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation
217564_s_at	CPS1	W80357	0.25	carbamoyl-phosphate synthetase 1, mitochondrial	chr2q35	chr2:211251080-211251421 (+)	50 ; urea cycle ; inferred from electronic annotation ; 6526 ; arginine biosynthesis ; inferred from electronic annotation ; 6541 ; glutamine metabolism ; inferred from electronic annotation ; 6807 ; nitrogen compound metabolism ; inferred from electronic annotation ; 19856 ; pyrimidine base biosynthesis ; inferred from electronic annotation ; 8152 ; metabolism ; inferred from electronic annotation	166 ; nucleotide binding ; inferred from electronic annotation ; 4087 ; carbamoyl-phosphate synthase (ammonia) activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 5524 ; ATP binding ; inferred from electronic annotation ; 16874 ; ligase activity ; inferred from electronic annotation ; 3824 ; catalytic activity ; inferred from electronic annotation ; 4086 ; carbamoyl-phosphate synthase activity ; inferred from electronic annotation ; 4087 ; carbamoyl-phosphate synthase (ammonia) activity ; inferred from electronic annotation
202996_at	POLD4	NM_021173	0.24	polymerase (DNA-directed), delta 4	chr11q13	chr11:66875927-66877520 (-)	6260 ; DNA replication ; traceable author statement ; 6260 ; DNA replication ; inferred from electronic annotation	3891 ; delta DNA polymerase activity ; traceable author statement ; 5515 ; protein binding ; inferred from physical interaction ; 16740 ; transferase activity ; inferred from electronic annotation ; 3887 ; DNA-directed DNA polymerase activity ; inferred from electronic annotation ; 16779 ; nucleotidyltransferase activity ; inferred from electronic annotation
211357_s_at		BC005314	0.23	aldolase B, fructose-bisphosphate	chr9q21.3-q22.2	chr9:103223479-103223890 (-)	6000 ; fructose metabolism ; traceable author statement ; 6096 ; glycolysis ; traceable author statement ; 6096 ; glycolysis ; inferred from electronic annotation	4332 ; fructose-bisphosphate aldolase activity ; traceable author statement ; 16829 ; lyase activity ; inferred from electronic annotation ; 4332 ; fructose-bisphosphate aldolase activity ; inferred from electronic annotation
238878_at	ARX	AA496211	0.23	aristaless related homeobox	chrXp22.1-p21.3	chrX:24931736-24932380 (-)	6355 ; regulation of transcription, DNA-dependent ; inferred from electronic annotation ; 7275 ; development ; inferred from electronic annotation ; 6350 ; transcription ; inferred from electronic annotation ; 45449 ; regulation of transcription ; inferred from electronic annotation	3700 ; transcription factor activity ; inferred from electronic annotation ; 3677 ; DNA binding ; inferred from electronic annotation
204705_x_at	ALDOB	NM_000035	0.23	aldolase B, fructose-bisphosphate	chr9q21.3-q22.2	chr9:103223479-103237926 (-)	6000 ; fructose metabolism ; traceable author statement ; 6096 ; glycolysis ; traceable author statement ; 6096 ; glycolysis ; inferred from electronic annotation	4332 ; fructose-bisphosphate aldolase activity ; traceable author statement ; 16829 ; lyase activity ; inferred from electronic annotation ; 4332 ; fructose-bisphosphate aldolase activity ; inferred from electronic annotation
202785_at	NDUFA7	NM_005001	0.22	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa	chr19p13.2	chr19:8282244-8292266 (-)	42773 ; ATP synthesis coupled electron transport ; inferred from electronic annotation	3954 ; NADH dehydrogenase activity ; inferred from electronic annotation ; 8137 ; NADH dehydrogenase (ubiquinone) activity ; traceable author statement ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 8137 ; NADH dehydrogenase (ubiquinone) activity ; inferred from electronic annotation
207200_at	OTC	NM_000531	0.21	ornithine carbamoyltransferase	chrXp21.1	chrX:38096239-38165543 (+)	50 ; urea cycle ; non-traceable author statement ; 6526 ; arginine biosynthesis ; non-traceable author statement ; 8652 ; amino acid biosynthesis ; inferred from electronic annotation ; 50 ; urea cycle ; inferred from electronic annotation ; 6520 ; amino acid metabolism ; inferred from electronic annotation ; 6526 ; arginine biosynthesis ; inferred from electronic annotation	4585 ; ornithine carbamoyltransferase activity ; non-traceable author statement ; 16597 ; amino acid binding ; inferred from electronic annotation ; 16740 ; transferase activity ; inferred from electronic annotation ; 4585 ; ornithine carbamoyltransferase activity ; inferred from electronic annotation ; 16743 ; carboxyl- and carbamoyltransferase activity ; inferred from electronic annotation
214476_at	TFF2	NM_005423	0.21	trefoil factor 2 (spasmolytic protein 1)	chr21q22.3	chr21:42639537-42644277 (-)	6952 ; defense response ; not recorded ; 7586 ; digestion ; traceable author statement
206262_at	ADH1C	NM_000669	0.21	alcohol dehydrogenase 1A (class I), alpha polypeptide ; alcohol dehydrogenase IB (class I), beta polypeptide ; alcohol dehydrogenase 1C (class I), gamma polypeptide	chr4q21-q23	chr4:100476673-100492926 (-)	6066 ; alcohol metabolism ; non-traceable author statement ; 6069 ; ethanol oxidation ; traceable author statement	4024 ; alcohol dehydrogenase activity, zinc-dependent ; non-traceable author statement ; 8270 ; zinc ion binding ; inferred from electronic annotation ; 16491 ; oxidoreductase activity ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 4024 ; alcohol dehydrogenase activity, zinc-dependent ; traceable author statement ; 5489 ; electron transporter activity ; traceable author statement ; 8270 ; zinc ion binding ; traceable author statement ; 4022 ; alcohol dehydrogenase activity ; inferred from electronic annotation ; 4022 ; alcohol dehydrogenase activity ; traceable author statement
242601_at	LOC253012	AA600175	0.20	hypothetical protein LOC253012	chr7q21.3	chr7:92655834-92656398 (-)
220421_at	BTNL8	NM_024850	0.20	butyrophilin-like 8	chr5q35.3	chr5:180258764-180310510 (+)
221132_at	CLDN18	NM_016369	0.19	claudin 18	chr3q22.3	chr3:139211748-139232694 (+)	16338 ; calcium-independent cell-cell adhesion ; inferred from sequence or structural similarity	5198 ; structural molecule activity ; inferred from electronic annotation ; 42802 ; protein self binding ; inferred from sequence or structural similarity ; 5515 ; protein binding ; inferred from sequence or structural similarity
209116_x_at	HBB; hemoglobin	M25079	0.19	hemoglobin, beta ; hemoglobin, beta	chr11p15.5	chr11:5203379-5204807 (-)	6810 ; transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; inferred from electronic annotation ; 15671 ; oxygen transport ; traceable author statement ; 15671 ; oxygen transport ; non-traceable author statement ; 30185 ; nitric oxide transport ; non-traceable author statement ; 45429 ; positive regulation of nitric oxide biosynthesis ; non-traceable author statement	5515 ; protein binding ; inferred from direct assay ; 8430 ; selenium binding ; inferred from direct assay ; 19825 ; oxygen binding ; inferred from direct assay ; 30492 ; hemoglobin binding ; inferred from direct assay ; 5344 ; oxygen transporter activity ; inferred from electronic annotation ; 5488 ; binding ; inferred from electronic annotation ; 5506 ; iron ion binding ; inferred from electronic annotation ; 19825 ; oxygen binding ; inferred from electronic annotation ; 20037 ; heme binding ; inferred from electronic annotation ; 46872 ; metal ion binding ; inferred from electronic annotation ; 5344 ; oxygen transporter activity ; non-traceable author statement
205815_at	PAP	NM_002580	0.16	regenerating islet-derived 3 alpha	chr2p12	chr2:79237640-79240387 (-)	6953 ; acute-phase response ; inferred from electronic annotation ; 6954 ; inflammatory response ; inferred from electronic annotation ; 7157 ; heterophilic cell adhesion ; traceable author statement ; 7275 ; development ; traceable author statement ; 8283 ; cell proliferation ; traceable author statement	5529 ; sugar binding ; traceable author statement ; 5529 ; sugar binding ; inferred from electronic annotation
214324_at	GP2	BF222483	0.14	glycoprotein 2 (zymogen granule membrane)	chr16p12	chr16:20227688-20229716 (-)
223447_at	REG4	AY007243	0.11	regenerating islet-derived family, member 4	chr1p13.1-p12	chr1:120138232-120153012 (-)		5529 ; sugar binding ; inferred from electronic annotation
238383_at	LOC389429	AI857688	0.07	hypothetical LOC389429	chr6q22.33	chr6:127943101-127954650 (+)
